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Abstract 
Patients frequently develop hypertrophic scar after extensive thermal injuries. 
Hypertrophic scar often causes significant functional, cosmetic and psychological 
impairment to the patient. It is characterized by erythematous, raised, inelastic, high 
cellularity, and excessive collagen formation. The pathophysiological mechanisms and 
aetiology of hypertrophic scar are still poorly defined. Nevertheless, recent studies have 
t 
shown that altered gene expressions in hypertrophic scar fibroblasts should be 
responsible for the formation of hypertrophic scar. A better understanding of the altered 
gene expressions in the hypertrophic scar fibroblasts, should therefore provide insight to 
the mechanisms of hypertrophic scar formation. We reported here the identification of 
differential gene expressions in the cultured hypertrophic scar fibroblasts by using 
differential display RT-PCR, with cultured normal skin fibroblasts from the same patient 
as the control. Three differentially expressed candidate fragments were identified using 
48 sets of primer combinations. One of these candidate fragments, B3, the level ofwhich 
was lower in the hypertrophic scar fibroblasts, was isolated and reamplified by its 
corresponding primer sets. After reamplification, two bands were detected in the normal 
skin fibroblasts sample but only one band was detected in the hypertrophic scar 
fibroblasts sample. These bands were cloned and sequenced. The sequences of these 
cDNA fragments were submitted to the Genbank databases for homology searching. One 
of those bands showed significant homology to both human thrombospondin 1 (TSP 1) 
gene and cytochrome b561 gene. Therefore, we hypothesized that the expressions of 
iii 
thrombospondin 1 and cytochrome b561 were down-regulated in the hypertrophic scar 
fibroblasts. Gene specific primers were designed to verify the expressions of these two 
genes in hypertrophic scar fibroblasts，as well as normal skin fibroblasts, using semi-
quantitative RT-PCR. The results showed that the expressions of both TSP 1 and 
cytochrome b561 were down-regulated in the hypertrophic scar fibroblasts. TSP 1 is an 
anti-angiogensis factor, and it is responsible for the recognition of the apoptotic cells by 
macrophages. The down-regulation of TSP 1 in fibroblasts may be responsible for the 
excessive microvessels and cellularity in the hypertrophic scar. To the best of the author's 
« 
knowledge, this is the first report on the expression of cytochrome b561 in dermal 
fibroblasts. The role of down-regulation of cytochrome b561 in the formation of 
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Abbreviations 
jag micro-gram 
jui , micro-litre “ 
A Adenine ~ ~ ‘ 
bp Base pair(s) “ “ 
C Cytosine “ “ 
cDNA Complementary deoxyribonucleic acid ‘ — 
Da - Dalton “~~ 
DEPC Diethyl pyrocarbonate .二、 
DIG Digoxigen “ 
DMEM Dulbecco's modified Eagle's medium 
dNTPs Deoxyribonucleotide-5-phosphate 
DTT Dithothreitol ” 
EDTA Ethylenediaminetetraacetic acid ~ 
G Guanine — 
HSF Hypertrophic scar fibroblasts 
ICE Interleukin-1 -converting enzyme ~ 
~M Molar 
mRNA Messenger ribronucleic acid 
NF Normal skin fibroblasts ~~ 
PCR Polymerase chain reaction ~ 
RNA Ribronucleic acid ~ 
RT-PCR Reverse transcription — polymerase chain reaction 
SDS Sodium dodecyl sulfate 
T Thymine 
TBE Tris-boric acid-EDTA buffer 
tPA Tissue plasminogen activator 
TSP 1 Thrombospondin 1 
^ A Urokinase plasminogen activator 
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Abbreviation Table for Amino Acid 
Amino Acid Three-letter One-letter “ 
Alanine A k A ‘ 
Arginine Arg R 
Aspaxagine Asn N 
Aspartic acid Asp D 
Asparagine or Aspartic acid Asx B 
Cysteine-' Cys C 
Glutamic acid Glu E 
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Glutamine Gln Q 
Glutamic acid or Glutamine Glx Z 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Theronine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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Chapter 1: Introduction 
r 
Hypertrophic scar is a common complication among patients suffering from 
extensive thermal injuries. The inelastic quality of the scar tissue and the extensive scar 
contraction seriously limit the mobility ofjoints, and even cause deformities. 
Humans have noted, and tried to solve this medical problem since the dawn of 
history. Neanderthal man of 60,000 B.C. sought a remedy for this malady and used herbs 
V 
as a treatment method. In approximately 1600 B.C., the first written record of the 
treatment of bum injuries appeared in the Ebers Papyrus (Haynes, 1987). However, over 
3500 years' investigation, the treatments of hypertrophic scar are still not entirely 
satisfactory and often only partially effective. 
The major obstacle to the development of effective and rationale treatment of 
hypertrophic scar is the ill-defined aetiology of hypertrophic scar. The mechanisms for 
the formation ofhypertrophic and/or normotrophic scar are still unknown. 
Nevertheless, recent studies have shown that the altered gene expressions of the 
fibroblasts in hypertrophic scar lie in the center of the pathogenesis of hypertrophic scar. 
Investigation of the altered gene expressions of the hypertrophic scar fibroblasts should 
be a promising approach to understand the pathogenesis. The impetus behind the present 
study is based on this rationale. 
1 
Chapter 2: Literature Review 
r 
Part I Hypertrophic Scar 
2.1 Definition of hypertrophic Scar 
Hypertrophic scar is characterized by excessive amount of scar tissue that is 
bulky, raised, erythematous, nodular and inelastic (Ketchum et al., 1977). Though there 
are several assessment methods developed lately, there is still no clear cut distinction 
between on hypertrophic normotrophic scar. The diagnosis of hypertrophic scar depends 
largely on the judgement of the clinician (Dietch et al, 1983). 
2.2 Pathology 
Histological studies showed that both the dermis and epidermis of hypertrophic 
scar are thicker than the normal skin, and the epidermis is almost completely lack of 
epithelial ridges. Nodular collagen structure occupies nearly the whole thickness of the 
dermis (Linares et al, 1972). 
Hypertrophic scar causes serious functional problems. The frequent occurrence of 
scar contraction seriously compromises cosmetic appearance and limits mobility of the 
joints. Its itchiness and heat intolerance cause serious problem to patient too. 
2 
\ . 
2.3 Epidemiology findings 
2.3.1 Ethnicity 
； Ethnicity has long been identified as an important risk factor to predict the 
occurrence of hypertrophic scarring. Generally, darker-pigmented races (Asian and 
Blacks) are more susceptible to developing hypertrophic scar or keloids. The incidence of 
hypertrophic scarring in darker-skinned races is also up to 15 times higher than in Whites 
(Stucker & Shaw, 1992). Another group noted a 2 times greater incidence ofhypertrophic 
scarring iii black populations when compared to Caucasians (Deitch et aL, 1983). 
2.3.2 Age 
Hypertrophic scar may develop at any age (Muir, 1990) Clinically, younger 
people scar more than older people. In general, approximately 88 percent of hypertrophic 
scars and keloids occurred in people less than 30 years old (Ketchum et al, 1974). 
2.3.3 Body location 
The location of the wound on the body is of great significance in the formation of 
hypertrophic scar. The areas most commonly involved are the stemum, upper back, and 
deltoid (Ketchum et al., 1977). Scars that cross joints or skin creases at right angles are 
especially proned to form hypertrophic scarring, possibly due to the constant compression 
forces (Rudolph, 1987). The buttocks and dorsal aspect of the foot also show a greater 
incidence of scarring (Dietch et al, 1983). On the other hand, Hypertrophic scar rarely 
occurs on the eyelids, genitals, palms, or soles. 
3 
2.4 Mechanism of cutaneous wound healing 
The process of wound healing, which involves cellular and extracellular matrix 
components, is an intricate and organized response to the tissue injury. Wound repair is 
not a simple linear process but it usually follows a specific time sequence (for an 
excellent review, see Clark, 1996). It can be categorized into three major steps as shown 
in Figure 2.1 including inflammation, re-epithelialization and tissue remodeling. These 
three phrases are not mutually exclusive but rather overlapping in time. 
^ 
1 , 
2.4.1 Phase I 一 Haemostasis and inflammation 
The events responsible for normal wound healing are initiated at the precise 
moment when tissue trauma occurs. Upon cutaneous injury, haemostasis is the earliest 
response and it is followed by inflammation. The process of inflammation can be divided 
into 2 steps, early and late. The early phase is characterized by neutrophil-rich infiltration 
whereas the late phase of inflammation is characterized by mononuclear cell-rich 
infiltration. 
4 
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Figure 2.1 Phases of cutaneous wound repair. Healing of a wound has been 
arbitrarily divided into three phases: (A) inflammation (early and late), (B) re-
epitheiialization and granulation tissue formation, and (C) matrix formation and 
remodeling. These wound repair processes are plotted along the abscissa as a logarithm 
oftime. The phases of wound repair overlap considerably with one another. Inflammation 
is divided into early and late phases denoting neutrophil-rich and mononuclear cell-rich 
infiltration respectively. In humans, wound contraction begins after granulation tissue is 
well established, as indicated by the arrow. Collagen accumulation begins shortly after 
the onset of granulation tissue formation, as indicated, (modified from Clark, 1996) 
5 
2.4.1.1 Haemostasis 
Severe cutaneous injury causes blood vessels disruption with concomitant 
extravasation ofblood constituents. As the platelets come into contact with the interstitial 
connective tissue, they aggregate and are activated (Furie & Furie, 1988). The activated 
platelets discharge their a-granule. Several adhesive proteins including fibrinogen, 
fIbronectin, thrombospondin, and von Willebrand factor VIII are released (Ruggeri et al., 
1993). The fibrinogen, once converted to fibrin by thrombin, adds to the fibrin clot. In 
addition, platelets release chemotactic factors to the blood leukocytes, fibroblasts and 
\ 
smooth muscle cells such as platelet-derived growth factor (PDGF), transforming growth 
factor alpha (TGF-a) and beta (TGF-p) (Spom & Roberts, 1992). 
2.4.1.2 Early phase of inflammation 
Early phase of inflammation is denoted as neutrophil-rich phase. Neutrophils 
arrive first in large numbers after wounding. Neutrophils primarily have an 
immunological function by clearing the initial rush of contaminating bacteria via 
phagocytosis (for an excellent review, see Martin, 1997). Neutrophil infiltration will 
slowly recede and cease within a few days if substantial wound contamination does not 
occur. In the meantime, degradation products of the complement cascade also activate the 
mast cells in the wound site and these activated mast cells release factors such as 
histamine, serotonin, and eicosanoids. These factors are vasoactive substrates that induce 
vascular permeability and chemotaxis of the leukocytes (for an excellent review, see 
Robson & Heggers，1992). 
6 
2.4.1.3 Late phase of inflammation 
Monocytes are recruited to the wound site no matter neutrophil infiltration resolve 
or persist. Their accumulation is stimulated by chemoattractants such as fragments of 
extracellular matrix proteins fNforis et al., 1982, Senior et al., 1984) complement 
component fragments (Marder et al., 1985) and cytokines (Pierce et al., 1989). These 
monocytes are converted into macrophages (Laszlo et aL, 1993) and armed to debride the 
injured tissue through phagocytosis (Brown & Goodwill，1988). In addition, adherence to 
extracellular matrix also stimulates monocytes to undergo metamorphosis into 
t 
inflammatory or reparative macrophages (Shaw et al., 1990). These different kinds of 
macrophages are able to secret a board range of cytokines or growth factors, including 
colony-stimulating factor-1 (CSF-1), tumor necrosis factor-a (TNF-a), PDGF, TGF_P, 
interleukin-1 (IL-1), interferon-gamma (y-IFN), insulin-like growth factor-1 (IGF-1), and 
interleukin-8 (IL-8) (for an excellent review, see Riches, 1996). The resolution of 
inflammation depends much on macrophage clearance of apoptotic cells (Savill et aL, 
1992). Moreover, macrophage is also involved in extracellular matrix degradation in later 
healing stage by secreting a number of metalloproteinases such as elastase, interstitial 
collagenase (MMP-1), stromelysin (MMP-3) and gelatinase B (MMP-9) (Hibbs et al, 
1987) 
2.4.2 Phase II - Re^pitheliallzation/ tissue formation 
Re-epithelialization begins within hours after injury. It is clear that rapid 
reestablishment of the epithelial barrier decreases victim morbidity and mortality 
(Woodley DT, 1996). In general, re-epithelialization involves multiple processes. They 
7 
include the migration of epidermal keratinocytes, followed by formation of granulation 
tissue by migration of fibroblasts and angiogenesis. 
2.4.2.1 Migration of epidermal keratinocytes 
The activated keratinocytes migrate to the wound site from the peripheral as well 
as from cut epidermal appendages throughout the wound bed. These keratinocytes 
undergo marked phenotypic alterations including retraction of intracellular tonofilament; 
dissolution of the interlinkage of the epithelial cells; and loss of tenacious binding 
\ 
between the epidermis and the basement membrane (Gabbiani et al., 1978). The 
migration of the keratinocytes is believed to be attracted by the growth factors as well as 
cytokines in the wound site, and is facilitated by the expression of cell surface receptors 
(Wenczak BA et al., 1992). It is also believed that the activated keratinocytes are able to 
secret various kinds of cytokines for autocrine or paracrine stimulation of other cells such 
as fibroblasts and endothelial cells (Wemer et al., 1992). 
2.4.2.2 Migration offibroblasts 
The entry of fibroblasts is crucial for wound healing. Fibroblasts penetrate the 
blood clot composed of fibrin and lesser amounts of fibronectin and vitronectin (Lark et ‘ 
al., 1985), and are attracted by chemotactic factors such as PDGF and TGF-P (Seppa et 
al., 1982, Postlethwaite et aL, 1987). The expression of the surface integrin receptors is 
important to facilitate the migration of fibroblasts (Welch et al., 1990). Movement into a 
cross-linked clot or any tightly woven extracellular matrix also involves an active 
proteolytic system that can cleave a path for migration (Steler-Stevenson et al., 1989). 
8 
Once the fibroblasts have migrated into the wound site, they gradually switch their major 
fUnction to synthesize protein such as fibronectin, collagen type I and collagen type III 
(Clark et al, 1995). Some of the fibroblasts differentiate into myofibroblasts to facilitate 
wound contraction (Desmouliere & Gabbiani, 1993). During normal wound healing, the 
number of fibroblasts and myofibroblasts decrease markedly through the transition from 
a fibroblast-rich granulation tissue to a relatively acellular scar tissue. The process is 
suggested to be strictly regulated by apoptosis (Desmouliere et al., 1995). 
Disorganization of this process may induce fibrotic disorders such as hypertrophic scar, 
^ 
keloid formation, and scleroderma. 
2.4.2.3 Angiogenesis 
Angiogenesis, the formation of new blood vessel, plays a critical role in 
supporting the survival of the cells in the wound site. Previous findings implied that 
angiogenesis may operate through chemotaxis and followed by endothelial replication 
(Folkman et al, 1982). Basic fibroblast growth factor (bFGF) was well characterized in 
its angiogenic property both in vitro and in vivo. Vascular endothelial growth factor 
(VEGF) is another potent angiogenic stimulator (Ferrara & Henzel，1989). Recently, 
other molecules such as TGF-a, TNF-a, angiogenin, angiotropin, IL-8, PDGF also have 
been shown to have angiogenic activity, (for an excellent review, see Iruela-Arispe & 
Dvorak, 1997) In addition, angiogenesis also relies on the activation of plasmin cascade 
(Bacharach et al., 1992) and an appropriate extracellular matrix in the wound bed 
OSficosia & Madri，1987). 
9 
2.4.3 Phase 丨11 - Tissue remodeling 
Cell maturation, cell apoptosis, and extracellular matrix remodeling make up the 
last and longest phase of wound healing. It is the process to retain the wound site back to 
f 
normal tensile strength and function. 
2.4.3.1 Cell maturation and apoptosis 
Once the wound is filled with granulation tissue and covered with a neoepidermis, 
Myofibroblasts contract the wound and facilitate wound closure. (Desmouliere & > 
Gabbiani, 1993). In normal wound healing, endothelial cells appear to be the first cell 
type to undergo apoptosis after wound closure, followed by myofibroblasts; leading 
gradually to a rather acellular scar (Desmouliere et al,, 1995). The mechanism that 
regulates apoptosis in wound healing is not clear but withdrawal of the growth factor and 
cytokines should play a critical role. 
2.4.3.2 Exrtacellular matrix remodeling 
As the granulation tissue invades the fIbrin clot, the originally extracellular matrix 
is lysed by the proteases. Fibroblasts begin to deposit a laige amount of flbronectin, 
which will then immersed in a sea of hyaluronan (Welch et al., 1990). Thus, the wound 
transcends the initial plasma-derived extracellular matrix to the latter cell-derived 
extracellular matrix. When the fibroblasts become mature, they deposit type III 
procollagen and type I procollagen and with a diminished production of fibronectin. The “ 
appearance of fibronectin followed by collagen in healing wound is consistent with the 
role offibronectin as a template for collagen fibril organization (McDonald et al, 1982). 
10 
Upon the maturation of granulation tissue, hyaluronan was replaced by other 
proteoglycans (Bertolami & Donoff，1982). 
Collagen is the major component of extracellular matrix protein and the 
/ 
deposition of collagen is always a dynamic balance between collagen synthesis and 
degradation. The degradation of collagen is controlled by various kinds of collagenase 
secreted by macrophages, epidermal cells, and fibroblasts (Hasty et aL, 1986). Cytokines 
such as TFG-P, PDGF, and IL_1 and extracellular matrix itself may play an important 
role in the modulation of collagenase and the inhibitor counterparts called tissue inhibitor 
\ 
of metalloproteinases (TIMP) (Spom & Roberts, 1992). During normal remodeling, the 
tensile strength of the wound continues to increase despite a reduction in the rate of 
deposited collagen synthesis (Levenson et aL, 1965). This gain in strength is associated 
with the structural modification and reorganization of the newly deposited collagen. 
However, the scar tissue can never attain the same tensile strength as the intact skin. 
2.5 Alteration of wound healing 一 Possible pathogenesis of 
hypertrophic scar 
Hypertrophic scar is characterized by raised, firm and reddish. It has been 
suggested that hypertrophic scar develops as a result of excessive deposition of 
extracellular matrix and failure of tissue remodeling (Ketchum et aL, 1974). Recent 
studies, however, have shown that abnormalities of the patients with hypertrophic 
scarring are observed in nearly all stages of wound healing. The summary of these 
findings was listed in Table 2.1. 
y' 
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Table 2.1 Summary of the pathogenic changes of the hypertrophic scar 
Wound Phase Pathological Changes “ 
<• 
Phase I -prolonging inflammation 
Inflammation -increase anti-collagen level in serum 
-increase IgE level 
-increase in allergic symptoms 
-increase mast cells, Langerhan cells and T-cells 
� 
Phase II -delayed re-epithelialization 
Re-epithelializationy^ -prolonging the present of activated keratinocytes 
tissue formation -increase angiogenesis 
-excessive scar contraction 
Phase III -high cellularity 
Tissue Remodeling -excessive production of extracellular matrix 
-reduce collagenase production 
-failure in apoptosis of endothelial cells and fibroblasts 
-increase bcl-2 protooncogene level 
-decrease Fas and ICE level 
-increase TGF-p expression 
12 
2.5.1 Changes in Phase \ - Inflammation 
Hypertrophic scars often occur after prolonged inflammation. An increase in 
percentage of the third degree bum was found to be directly proportional to the serum 
level of anti-collagen antibody. In addition, some bum patients have a higher level of 
immunoglobulin E (IgE) than in normal people and an increase in allergic symptoms is 
reported in patients with keloids or hypertrophic scars (Smith 1997). 
Mast cell, which originates from undifferentiated mesenchymal cell, was found 4 
times as many in hypertrophic scar as in normal skin and 1.5 times as many as in mature 
scars (Kischer and Bailey, 1972). Activated mast cell releases its granules, which contain 
factors such as histamine, serotonin, eicosanoids, and polysaccharides. All these factors 
are suggested to be vasoactive substances that increase vascular permeability and 
chemotaxis of the leukocytes. 
In the active phase of hypertrophic scars there are abundant presence of 
Langerhans cells and T-cells, but a low presence of natural killer cells and the absence of 
B lymphocytes (Castagnoli et al, 1997). Approximately 70 percent of T-lymphocytes 
present in the hypertrophic scars were activated with positive immunostaining of anti-
HLA-DR and IL-2 receptor and their level is significantly higher than in normotrophic 
scars. It has also been showed that in hypertrophic scars, activated infiltrating cells are 
capable of producing TNF p and IL-lp increase significantly. In contrast, the percentage 
of TNF-a-positive cells in hypertrophic scar is significantly lower than in normotrophic 
scar (Castagnoli et al, 1993). 
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2.5.2 Changes in Phase II 一 Re-epithelializatlon/ tissue formation 
Most hypertrophic scars commonly occur after re-epithelialization has been 
delayed (Deitch et al, 1983). Activated keratinocytes are a feature of the early stages of 
re-epithelialization, and this activation should cease after complete wound closure. 
However, hyperproliferative keratins K6, K16 and K17 were expressed in interfollicular 
epidermis keratinocytes in hypertrophic scar. (Machesney et at，1998). On the other hand, 
K16 can only be found in the basal keratinocyte layer in normal skin. These results 
suggest that the keratinocytes in hypertrophic scar epidermis have entered an alternative 
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differentiation pathway and are expressing an activated phenotype. 
Hypertrophic scars are always characterized by red and erythematous, owing to 
excessive microvessels in the hypertrophic scar. In addition, most of the microvessels are 
partially or completely occluded (Kischer & Shetlar，1979). The rich network of 
microvessels is initially disposed in an irregular pattem, but when the collagen nodules 
begin to form, the microvessels appear peripheral and encompass the main body of the 
nodules as a net (Kischer and Brody, 1981). The occlusion may be due to the increased 
number of endothelial cells of the microvessels. Hypoxia in hypertrophic scar may be one 
of the factors that induce vascularization. Previous study reported that hypoxia enhanced 
the expression of vascular endothelial growth factor (VEGF) in dermal fibroblasts, and 




2.5.3 Changes in Phase Ill-Tissue remodeling 
Serious disorders in tissue remodeling are found in the hypertrophic scar both in 
the cellular level and protein level, as it is always characterized by excess extracellular 
f 
mafrix protein and relatively high cellularity compare with normotrophic scar or normal 
skin. Fibroblast has been suggested to play a crucial role in the disorder of this healing 
phase, and will be discussed further under the section 2.3.2: The Role of Fibroblasts in 
the Formation ofHypertrophic Scar. 
Failure in the apoptosis of endothelial cells may be another important factor that » 
promotes the formation of hypertrophic scar. Apoptosis of microvessels contributes 
significantly to the regression of the scar. It is always initiated prior to the apoptosis of 
myofibroblasts. A mature scar, whether derived from hypertrophic or normotrophic scar, 
has decreased vascularity. However, highly vascular network is found around the nodule 
of hypertrophic scar (Kisher et aL, 1982), and it indicates the reduction of apoptosis 
endothelial cells as expected. 
The bcl-2 protooncogene, a member of a multigene family, is capable of blocking 
apoptosis although the underlying mechanism is still undefined. Recent study has 
reported that the expression of the bcl-2 gene protein in the peripheral blood mononuclear 
cells ofbum patients with hypertrophic scar was significantly elevated compared with the 
matched control cohort (Wassermann RJ et al, 1997). Two apoptosis-inducing proteins, 
Fas and ICE, however, were lower in the hypertrophic scar fibroblasts than in the 
surrounding skin fibroblasts. The increased level of bcl-2 and decreased levels ofFas and 
ICE may be responsible for the delayed cell apoptosis in the hypertrophic scar. 
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2.6 The Role of fibroblasts in the formation of hypertrophic 
scar 
2.6.1 Functions of fibroblasts in wound healing 
Fibroblast is the most abundant cell type in the skin. In normal uninjured skin, 
fibroblasts are quiescent throughout the connective tissue matrix. After wounding, 
fibroblasts are activated and migrated from the adjacent tissue into the wound site (Ross 
et al., 1970). Once the fibroblasts have migrated into the wound, they gradually switch * 
their major function to extracellular matrix protein synthesis (Welch et aL, 1990) 
including fibronectin, collagen and proteoglycan. Besides extracellular matrix protein, 
activated fibroblasts also produce a board range of cytokines to facilitate wound healing 
(Bennett et aL, 1993). Some of the fibroblasts differentiate into myofibroblasts to 
facilitate wound contraction (Desmouliere & Gabbiani, 1993). Fibroblasts are also 
responsible for tissue remodeling by expression ofproteases. 
2.6.2 Suggested aetiological role in the formation of hypertrophic scar 
fibroblasts 
The pathogenesis changes of the fibroblasts in the hypertrophic scar are listed in 
Table 2.2. 
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Table 2.2 The pathogenesis changes offibroblasts in hypertrophic scar 
Types ofDisorder Pathological changes 
Fibroproliferation Disorder -prolonging the presence of myofibroblasts 
-increase the number of fibroblasts 
Extracellufer Matrix -increase collagen I and III production 
Remodeling Disorder -elevated ratio of collagen III to collagen I 
k 
-narrower collagen fibrils 
-decrease collagenase production 
-increase chondroitin-4-sulfate production 
-decrease hyaluronic acid production 
Others -increase TGF-P production 
-decrease nitric oxide synthase activity 
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2.6.2.1 Fibroproliferatidn disorder 
During wound healing, some of the fibroblasts differentiate into myofibroblasts 
(Desmouliere & Gabbiani，1993). Myofibroblasts has been suggested to be the cell 
responsible for wound contraction (Gabbiani, 1996). After wound closes, myofibroblasts 
are gradually reduced in number through apoptosis. They are absent in normal dermis or 
mature scar but are found abundant in hypertrophic scar. The presence of myofibroblasts 
is suggested to be the main cause of pathological scar contraction, which leads to serious 
deformities. 
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2.6.2.2 Extracellular matrix remodeling disorder 
a) Collagen 
Collagen is the basic structural fibrous protein found in the skin as well as in the 
scar tissue. The most abundant type of collagen is type I collagen and followed by type 
III collagen. Early healing wounds are characterized by an elevated ratio of type III to 
type I collagen which may persist in hypertrophic scar (Bailey et al, 1975). Persistently 
elevated level of type III collagen may be an indicator of immature healing tissue. 
Hypertrophic scar is also characterized by the presence of nodules of thin and densely 
packed fibers and such structure is never seen in normal skin (Linares et al, 1972). When 
examined by electron microscopy, the collagen fibrils in the nodules are narrower than 
those in normal dermis. The fibrils of normal dermis are round and ovoid in cross section 
whereas those in hypertrophic scar are distinctly irregular and angular. 
The altered collagen level may be due to the alteration of collagen synthesis by 
the fibroblasts in the hypertrophic scar. Keloid fibroblasts have an autonomous capacity 
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to synthesize collagen at a significantly increased level compared with the fibroblasts in 
normal scar and normal skin (Diegelmann et al, 1979). Cultured fibroblasts from 
hypertrophic scars showed marked increase in expression of mRNA for type I and type 
4 
III procollagen than in normal skin (Ghahary A et al, 1993, Arakawa et al, 1996). 
Excessive collagen in the hypertrophic scar can also be a consequence of reduced 
degradation of the collagen. Degradation of collagen is mediated by collagenase and then 
by gelatinase. Quantitative analysis demonstrated significantly lower collagenase activity 
in hypertrophic scar-derived fibroblasts compared with that in the normal skin-derived 
\ 
fibroblasts (Ghahary et al, 1996, Arakawa et al, 1996). Reduced collagenase mRNA 
expression was also observed. 
b) Proteoglycan 
A significant increase in water content in hypertrophic scars was noted. It is 
almost certain to be a consequence of the increased concentration of proteoglycans, 
which are believed to regulate tissue hydration. Proteoglycans are a grouped of proteins 
carrying glycosaminoglycan (GAG) side-chain. The predominant GAGs in dermis are 
dermantan sulfate ¢)8) and hyaluronic acid (HA), with small amounts of chondroitin 
sulfate (CS). Chondroitin-4-sulfate, which is barely detectable in normal skin, readily 
detected in hypertrophic scar and especially elevated in the nodules (Shetlar et al, 1977), 
whereas the concentration of HA in hypertrophic scar is lower. However, the mechanism 




The expression of CD44, which is a cell adhesion molecule and surface receptor 
for hyaluronan, is markedly increased in hypertrophic scar fibroblasts compared with 
normal skin fibroblasts (Messadi & Bertolami，1993). 
/ 
2.6.2.3 Other differentially expressed factors 
TGF-p is the most wildly studied cytokine in the scar formation. Many of the 
cellular effects ofTGF-p in vitro or in vivo can potentially contribute to the formation of 
hypertrophic scar. TGF-P can cause rapid formation of granulation tissue at the site of « 
subcutaneous injection, and it also can stimulate collagen production by the fibroblasts 
(Roberts et al, 1986). TGF-pi induces a-smooth muscle actin expression, which is an 
important feature of myofibroblast in quiescent cultured fibroblasts (Desmouliere et al, 
1993). Enhanced mRNA expression of TGF-p has been observed in the hypertrophic 
scar-derived fibroblasts (Ghahary et al, 1993). The same results are displayed in vivo too 
(Scott et al, 1995, Zhang K et al, 1995). As in human normal skin, mRNA expression of 
TGF_P type I receptor (RI) and type II receptor (RII) is only clearly detectable in the 
epidermis, epidermal appendages, vascular cells, and only a small number of dermal 
fibroblasts. In contrast, granulation tissue fibroblasts show strong expression of both 
receptor types which markedly decreases in the normal healing wounds after tissue 
remodeling. RI and RII over-expressing fibroblasts are found in high densities in the 
hypertrophic scar up to 20 months post-bum. These results suggest that autocrine 
stimulation ofTGF_P is present in the hypertrophic scar fibroblasts (Schimid et al, 1998). 
Other factors were also found differentially expressed in hypertrophic scar 
fibroblasts. Insulin-like growth factor-I binding protein 3 (IGFBP-3), which can regulate 
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the activity of IGF-I, has been shown to be significantly elevated in the hypertrophic scar 
fibroblasts (Hathaway et al, 1994). Nitric oxide fNO) may play a role in wound healing 
and scar formation through its vasodialation and anti-proliferative effects. The 
concentration o fNO in the cultured hypertrophic scar fibroblasts is lower than the normal 
skin fibroblasts. The activity of the nitric oxide synthase QSfOS) in the cytosol of 
hypertrophic scar fibroblasts is also significantly lower (Wang et al, 1997). The low level 
of endogenous NO in hypertrophic scar fibroblasts may account for the high cellularity of 
post-bum hypertrophic scar. � 
2.7 Treatment of hypertrophic scar 
The therapeutic effects of existing treatments to control hypertrophic scar formation 
are still very limited. Dmgs such as colchicine, D-penicillamine, and BAPN have been 
shown to retard some phases of collagen synthesis or cross-linking and to decrease 
secretion of collagen from fibroblasts (Rockwell et al., 1989). Intralesion injection of 
corticosteroid triamcinolone has been used for many years to encourage keloid regression 
and it appears to enhance collagenase production. Surgical excision followed by 
autograft, is the most widely accepted treatment of hypertrophic scar nowadays. Pressure 
therapy has been noted to have a thinning effect on the scar, and compression of scar 
tissue reduces tissue edema and encourages scar maturation (Leung & Ng, 1980，Jensen 
& Parshley，1984). Radiation and lasers are also applied to destroy local fibroblasts 
(Rockwell et al., 1989, Goldman & Fitzpatrick，1995). Recently, clinical trial of 
intralesional interferon gamma treatment has demonstrated reduction in linear dimension 
of the scar and flattened out (Larrabee WF et al., 1990). 
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However, none of these treatments are entirely satisfactory: Uses of steroid or 
other drugs are associated with systemic side effects and not suitable for large area scars. 
Surgical revision may lead to recurrence. Pressure garments must be wom for several 
/ 
months to be effective (Rockwell et al., 1989). 
These treatments are slow, expensive, labor-intensive and often only partially 
effective. A further understanding of the pathogenesis as well as the alteration of gene 




Part II Differential Display 
2.8 Current approaches for the studies of differential gene 
expression 
In the past, identification of the differences between two biological situations 
could only be done by subtractive hybridization. In 1992, two PCR-based strategies were 
developed for fingerprinting of expressed mRNA as cDNA tags. One was called RNA 
arbitrary PCR (RAP-PCR) (Welsh et al, 1992) and the other was named differential « 
display RT-PCR (DD-RTPCR) (Liang and Pardee, 1992). 
2.9 Comparison amongst different approaches 
These PCR-based strategies have the advantages of being faster and less labor-
intensive compared with the conventional subtractive hybridization. In terms of 
sensitivity, rare mRNAs can also be identified, and less amount of RNA is required by 
these 2 methods (Liang & Pardee，1992). Unlike subtractive hybridization, for the 
identification of transcripts present in one sample but not in the other, these methods 
enable one to simultaneously compare more than two samples and identify transcripts 
with various different behaviors, including up- and down-regulation, and transient 
changes. 
Arbitrarily primed PCR was originally developed to detect genomic 
polymorphism as a genetic mapping method. However, DDRT-PCR uses combinations 
of arbitrary primers and anchored cDNA primers to generate cDNA fragments that 
originate mostly from poly(A) tail mRNA and extends about 50-600 nucleotides 
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upstream (Bauer et al, 1993). Both methods are able to detect differences in gene 
expression of a certain percentage of expressed genes but theoretically, DDRT-PCR is 
able to generate a largely complete pattem of all mRNAs expressed using a reasonable 
f 
number of primer pairs (Bauer et al, 1993). 
2.10 The strategy of differential display RT-PCR (DDRT-PCR) 
The strategy of DDRT-PCR is shown in Fig 2.2. The method consists of 5 steps 
(Bauer et aL, 1993): (1) The total RNA is reverse transcripted in fractions using a set of 
anchored oligo-d(T) primers; (2) amplification of cDNA specifies from each fraction 
using a set of arbitrary primers and anchored oligo-d(T) primers; (3) electrophoretic 
separation of the resulting fragments; (4) reamplification of fragments that are different 
between two situations followed by cloning and sequencing; confirmation of differential 
expression by an independent RNA analysis technique, psforthem blotting, RT-PCR, 
RNase protection assay). 
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Extraction of total RNA with DNase treatment 
X ^ 
/ 
RT-PCR with a selected anchored oligo-(dT) primer 
and arbitrary primers 
. ^ 
Band selection t 
^^ C^  
Cloning and sequencing analysis 
^ 0 " 
Confirmation of differential expression: 
Northern Blot, RT-PCR, RNase Protection Assay 
Figure 2.2 Schematic flow chart of differential display RT-PCR 
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2.11 The application of DDRT-PCR to identify differentially 
expressed genes 
Recently, DD-RTPCR has been successfully applied to identify the differentially 
expressed genes in cell differentiation (Shima et al, 1995), embryogenesis (Adati et al, 
1995, Momiyama T et al, 1995), nerve injury (Kiryu et al, 1995), hormone regulation 
(Agarwal et al, 1995, Chapman et al, 1995, Nitsche et al, 1996), organ development 
(Zhang et al, 1998), cancer (Liang et al, 1992, Liang et al, 1994), as well as in other 
situations. (Douglass et al, 1995). All these findings suggested that DDRT-PCR is a 
powerful method to identify differentially regulated genes under 2 or multiple conditions. 
Therefore, this method should be capable of identifying the differentially 
expressed genes between the hypertrophic scar fibroblasts and normal skin fibroblast 
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Chapter 3: Aims and Strategies 
Hypertrophic scars cause fimctional and cosmetic problems for the patients. 
However, the pathogenesis of hypertrophic scar is still unclear and none of the presently 
available treatments is effective and satisfactory. 
Previous studies showed that the formation of hypertrophic scarring was mainly 
contributed by the pathological changes of the fibroblasts and these changes are in 
transcriptional levels. Altered gene expressions of hypertrophic scar fibroblast lie at the 
center of these pathological changes. However, current knowledge of the altered gene 
expressions in hypertrophic scar is still not enough to elucidate the pathogenesis of 
hypertrophic scarring. It is believed that some important altered gene expression(s) have 
not been identified yet. 
Comparisons of gene expressions between the hypertrophic scar fibroblasts (HSF) 
and normal skin fibroblasts fN"F) should be able to provide valuable information to 
understand the underlying pathophysiological mechanism of hypertrophic scarring. 
Hence, effective and rational treatment for hypertrophic scar can be developed. 
The objective of this study is to compare the gene expressions and identify the 
differentially expressed gene(s) between the hypertrophic scar fibroblasts and normal 
skin. 
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The strategies of this study are listed as follow: 
1) To develop the human hypertrophic scar fibroblast culture model. 
2) To compare the gene expressions between the hypertrophic scar fibroblasts (HSF) 
( 
and normal skin fibroblasts QSfF) by using differential display RT-PCR approach. 
3) To identify these differentially expressed gene(s) by cloning and sequencing. 




Chapter 4: Materials and methods 
4.1 Materials 
/ All chemicals not specified in table 4.1 were obtained from Merck 
(Whitehouse Station, NJ, USA), Sigma (St Louis, MO，USA), Gibco BRL, and 
Riedel-de Haen (Seelze，Germany). 
Table 4.1 Materials used 
Material： ~ Source 
Tissue culture 
Dulbecco's modified Eagle medium (DMEM) Sigma 
Fetal calf serum (FCS) Gibco BRL 
Penicillin-Streptomycin (PS) Gibco BRL 
Trypsin Gibco BRL 
Immunohistochemical staining 
Mouse anti- human keratin antibody Dako 
Mouse anti-human prolyl-4-hydroxylase antibody Dako 
ABC staining kit Vector 
3,3-diaminobenzide (DAB) Sigma 
Total RNA extraction 
TRIZOL Gibco BRL 
Diethylpyrocarbonate (DEPC) Sigma 
DNase I digestion 
DNase I Boehringer Mannheim 
DDRT-PCR 
Differential Display Kit Display Systems Biotech 
[ a , p ] dATP Amersham 
Polyacrylamide gel electrophoresis 
GEL-MIX 6 Gibco BRL 
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Reverse transcription 
RNase inhibitor Boehringer Mannheim 
Superscript II reverse transcriptase Gibco BRL 
PCR 
Themoprime plus Taq Advance Biotechniques 
Agarose gel staining 
SYBR Green I Molecular Probe 
Molecular cloning and screening 
TA cloning kit Invitrogen 
EcoK I Boehringer Mannheim 
Cycle sequencing 
Ds cycle sequencing system Gibco BRL 
) 
[y,3p] ATP Amersham 
Southern Blot 
Nylon membrane, positive charge Boehringer Mannheim 
DIG Easy Hyb, hybridization buffer Boehringer Mannheim 
DIG-dUTP Boehringer Mannheim 
DIG Oligonucleotide Tailing Kit Boehringer Mannheim 
DIG nucleic acid detection kit Boehringer Mannheim 
DNA marker 
(j>Xl74 DNAy'Hae III fragments Boehringer Mannheim 
1 kb DNA ladder Gibco BRL 
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4.2 Clinical specimen collection 
Human hypertrophic scar sample was collected from a patient with full 
thickness bums who underwent routine bum excision and autografting procedures at 
the Prince of Wales Hospital. Normal skin sample was obtained form the donar graft 
site from the same patient. 
4.3 Primary explant culture 
Primary human fibroblast culture was established using a modified protocol as 
described by Ghahary et al. (1993). Explants of the scar sample and the normal skin 
were washed by PBS. Specimens were dissected free of fat and minced into pieces 
less than 1 mm in diameter in all dimensions. About ten pieces of tissue were 
distributed on a 60 mm diameter culture dish and 3ml of DMEM and supplemented 
with 10% FCS and 1% PS was added to each dish. The cultures were incubated in a 
37°C incubator with 5% CO2 and air at 95% relative humidity. The medium was 
changed every 3 or 4 days. Cells grew outward from the tissue after 2 to 3 weeks and 
reached confluence about 1 to 2 weeks after outgrowth. Once the cells reached 
confluence, they were washed with 5ml PBS 3 times and then digested with 1ml 
0.25% trypsin for 5 min. The cells were collected, counted and seeded onto the 25cm^ 
culture flask. After the cells reached confluence, they were treated with trypsin as 
2 
previously described and were seeded onto the 75cm flask. When they reached 
confluence again, the total RNA of the fibroblasts was extracted. 
Part of the fraction of cells was seeded onto the glass slide in a 120 mm 
diameter culture dish after the second passage. The cultured cells were grown to reach 
confluence and immunohistochemically stained with anti-keratin, which is the maker 
of keratinocyte, as well as anti-prolyl-4-hydroxylase, which is the surface marker of 
fibroblast. 
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4.4 lmmunohistochemical staining 
The glass slides with the cells were washed with PBS 2 times and fixed in 
acetone for 10 min at room temperature, followed by 3 times 5 min washes in PBS. 
t 
Then the slides were incubated in the methanol for 10 min and the washing steps 
repeated, and followed by a blocking step in PBS containing 5 % normal rabbit serum 
for an hour at room temperature. 1:400 dilution of the primary antibodies were added 
onto the slides and the slides were incubated at 37®C for an hour. After 3 times 5 min 
washes with PBS, the slides were incubated with biotinylated secondary antibodies in 
V 
1:200 dilution in PBS, 5% normal rabbit serum at 37°C for an hour. After applying 
ABC solution，DAB with hydrogen peroxide was added as a substrate to develop the 
colour. 
4.5 Total RNA extraction 
Total RNA was isolated from the confluent fibroblasts by TRIZOL and the 
protocol was followed the manufacturer manual. The isolation method was modified 
from Chomczynski and Sacchi (1987). In brief, the confluent fibroblast from a 75 cm^ 
flask was lysed with the TRIZOL reagent. 0.2ml per 1 ml of TRIZOL of chloroform 
was added and the mixture was centrifuged at 4,000 g for 15 min. The supernatant 
was transferred to a new tube and 0.5 ml per 1 ml of TRIZOL of isopropanol was 
added to the supernatant to precipitate the RNA. The content was centrifuged at 4,000 
g for 10 min and the supernatant was discarded. The pellet was washed with 1 ml of 
70% ethanol per 1 ml of TRIZOL and the ethanol was discarded after washing. The 
RNA was air dried for about 4 hours. Disposable plasticwares were used and DEPC 
treated H2O was used for all reagents throughout the whole process. The amount and 
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the purity of RNA was quantified with OD260 as well as OD280 (Genequant II， 
Pharmacia Biotech). 
4.6 DNase I digestion 
. ' 3 0 jag of total RNA was digested with RNase-free DNase I at 37 °C for an 
hour to ensure lack ofDNA contamination. 40 ml ofTE saturated phenol/ chloroform 
(1:3) was added and centrifuged at 10,000 xg for 10 min. at 4 � C . The upper phase 
was transferred to a new Eppendorf tube. The total RNA was precipitated with 
isopropanol and washed with 70% ethanol as previously described. Air-dried RNA 
was resubened into DEPC treated H2O and quantified as previously described. 1 i^g 
of the DNase I treated total RNA with ethidium bromide and DNA loading buffer was 
electrophoresed on an ordinary 0.8% agarose gel at 80V for 20 min. Only the RNA 
without degradation will be used for further investigation. 
4.7 Differential display-RTPCR (DD-RTPCR) 
The protocol was based on the original procedure by Liang and Pardee (1992). 
According to the original procedures, 9 anchored oligo-d(T) T1 lVN should be used to 
construct the complementary DNA. In our study, only DP#9 5 ‘ TTTTTTTTTTTGG, 
DP#8 5,TTTTTTTTTTTGC, DP#7 5'TTTTTTTTTTTGA, DP#6 
5,丁丁丁丁丁丁丁丁丁丁丁�0, 4 sets of primers were applied in our study. All samples were 
run in duplicate. Each reverse transcription reaction contained l^ig total RNA, 
75pmole anchored oligo (dT)，250^M dNTP, 1 x first strand cDNA synthesis buffer 
30 units ofRNasin, 30 units ofReverse Transcriptase M-MuLV and was incubated in 
40°C for one hour. The PCR reaction contained lOpmole arbitrary primer (UP#l-12). 
The primer sequences are as follows: 
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Primer name Sequence 
~XMl “ 5' GAT CAT AGC C 
UP#2 5' CTG CTT GAT G 
UP#3 5' GAT CCA GTA C 
UP#4 5, GAT CGC ATT G 
UP#5 5' AAA CTC CGT C 
UP#6 5 ,TGGTAAAGGG 
UP#7 5，GAT CAT GGT C 
UP#8 5' TTT TGG CTC C 
V 
UP#9 5 ,GTTTTCGCAG 
UP#10 5' TAC CTA AGC G � 
UP#11 5，GAT CTG ACA C 
UP# 12 5 ‘ GAT CTA ACC G 
and l.O^iCi [a-^^P] dATP, 1 unit ofdisplay TAQ FL DNA Polymerase, 15^iM dNTP. 
The PCR amplification profile was an initial denaturation at 94°C for 5 min followed 
by 40 cycles of 94 °C for 30 s, 40 °C for 90 s, and 72 °C for 60 s and a final 5 min 
extension at 72 °C. The PCR reactions were run in the thermocycler (MJ Research). 
4.8 Polyacrylamide gel electrophoresis 
3 [i\ of DDRT-PCR product with 2 i^l DNA loading buffer (20% v/v Ficoll, 
lOmM EDTA, pH=8.0，0.1 % w/v bromophenol blue, 0.1% w/v xylene cyanol FF for 
native gel; 95% v/v formamide, lOmM EDTA, pH=8.0, 0.1 % w/v bromophenol blue, 
0.1% w/v xylene cyanol FF for denature gel) was denatured at 95 °C for 2 min prior to 
running and displayed on nondenature 6% polyacrylamide gel or GEL-MIX 6 
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denature sequencing gel in a IX TBE buffer (O.lM Tris-HCl, O.lM boric acid, 2mM 
EDTA pH=8.0). The gel was run at 40 watt until the first dye (bromophenol blue) has 
migrated through the entire gel. The gel was then transferred to Whatman paper and 
was dried under vacuum at 75 °C for an hour. Kodak BIOMAX MR film was 
r 
exposed to the gel 48 hours at -70 °C with an intensifying screen. 
4.9 Reamplification of the differentially expressed fragments 
Bands of interest were excised from the gel and transfer to Eppendorf tubes 
separately. The remained gel was re-exposed to the X-ray film to confirm the bands « 
t 
were cut precisely. 100 i^l ofwater was added and heated at boiling water bath for 15 
min. 5 ^1 of eluted product was reamplified by PCR reamplification. The 
amplification protocol was carried out with the cycle protocol given for DD-RT-PCR, 
except for the annealing temperature used 4l^C instead of 40�C. 10 i^l of the reaction 
mixture was run on a 2% native agarose gel and stained with SYBR Green I for 20 
min to estimate the size of the DNA fragment and separate the unresolved DNA 
fragments. The DNA fragment was excised from the agarose gel and another 
reamplification was performed. 
4.10 Molecular cloning of the DNA fragments 
These DNA fragments were cloned by with the TA cloning kit. In brief, the 
PCR product was ligated with the vector pCR2.1 for a 1:1 molar ratio with T4 DNA 
Ligase. The map of the vector pCR2.1 was shown in Figure 4.1. The ligation reaction 
was incubated at 14°C ovemight. Then the ligated vector was transformed into the 
DH5a competent cells by heat shock for 30 sec in the 42°C and was shaken 
horizontally at 37�C for an hour at 225rpm in a rotary shaking incubator. 50 i^l, 100 i^l 
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and 200 ^1 from each transformation vial was spread on the LB agar plates containing 
50 ^ig/ml kanamycin, 1.6mg X-gal and 4 mM IPTG. The plates were then inverted 
and incubated at 37 °C for 18 hours. 
4.11 Screening and miniprep of the plasmid DNA 
12 white or pale blue colonies were picked for each plate and these colonies 
were grew at 37 °C ovemight in 2 ml LB broth containing 50 p,g/ml of kanamycin. 
The minipreparation of the plasmid DNA was followed by the alkaline lysis method 
presented by Ish-Horowicz and Burke (1981). The pellected bacteria was resuspended 
in 0.1 ml of solution I (50 mM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH=8.0) 
and lysed with 0.2 ml solution II (0.2 M NaOH, 1 %SDS), and neutralized by adding 
0.15 ml solution III (30 mM potassium acetate, 11.5 % acetic acid). The mixture was 
further purified by phenol/chloroform extraction and ethanol precipitation. The 
resulting DNA was resuspended with distilled H2O and quantified with OD260 
(Genequant II, Pharmacia Biotech). 2 ^g of isolated plasmid was restrictedly digested 
with EcoR I and was checked for inserts by 1.2% agarose gel electrophoresis and 
SYBR Green I staining. 
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M13 r^vdfS^primN ste: bs&&& 206-221 
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Figure 4.1 The map of the vector pCR2.1. The inserted PCR product is flanked 
on each side by EcoR I sites. The arrow indicates the start of transcription for the T7 
RNA polymerase. 
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4,12 Cycle sequencing 
Plasmid with the insert was sequenced by dsDNA Cycle Sequencing System 
(Gibco BRL) which was based on the dideoxy chain-termination procedure of Sanger 
et al.(1977 ). In brief, 1 pmole of M13 reverse sequencing primer was labeled with 5 
pmole of [Y-33p] dATP with 1 unit of T4 polynucleotide kinase at 37 °C for 15 min 
and the reaction was terminated by incubation at 55�C for 5 min. 0.1 i^g of the 
plasmid; 4.5 i^l of 10X Taq sequencing buffer, 2.5 units of Taq was added to the end-
labeling reaction mixture. The final volume was adjusted to 36 ^1 with distilled H2O. 
8 ml of this reaction mixture was added to 2 ^1 of termination mix contained either 
ddATP, ddCTP, ddTTP, ddGTP. The thermal cycle reaction was performed in the 
thermal cycler (MJ Research) and the protocol was 30 cycles of a denaturation step at 
95 °C for 30 s，an annealing step at 50 °C for 30 s, and an extension step at 70 °C for 
60 s, followed by 10 cycles of a denaturation step at 95 °C for 30s and an extension 
stepat70 °Cfor 60 s. 
The reaction product was electrophoresed through GEL-MIX 6 sequencing 
gel. The gel was run at 60 watts and the second loading was added after 2.5 hrs of the 
first loading. The third loading was added after 1.5 hr of the second loading. Gel 
transfer and autoradiography were performed as previously described except the 
exposure time was 72 hours instead of 48 hours. 
4.13 Data analysis 
The sequences were submitted to Web-Cutter 2.0 to analysis the restriction 
sites of the fragment. The address of Web-Cutter 2.0 is: 
http://www.firstmarket.com/cutter/cut2.html 
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The open reading frame of the sequences was analysis by ORF. The address of ORF 
is: 
http://www.ncbi.nlm.nih.gov/gorf/gorf.html 
The sequences of the nucleic acid and amino acid were also submitted to Basic Local 
Alignment Search Tool (BLAST) to analysis the homology of the sequences to the 




Sequence specific primers were designed with the program OLIGO 4 to 
analysis the expression of the genes in the NF and HSF samples by reverse 
transcription follow by polymerase chain reaction (RT-PCR). Each reverse 
transcription reaction contained l^ig total RNA, 100 pmole oligo (dT), 2.5 ^M dNTP, 
1 X first strand cDNA synthesis buffer 10 units of RNasin, 1 unit of Reverse 
Transcriptase SuperScript II (Gibco BRL) and was incubated in 42°C for one hour. 
The PCR reaction contained IX PCR buffer, 25 pmole primers, 1 unit of 
Thermoprime plus Taq DNA Polymerase, 2.5 i^M dNTP. The cycle protocol was 10 
or 15 or 35 cycles of a denaturation step at 94 °C for 60 s, an annealing step at 60 °C 
for 60 s, and an extension step at 72 °C for 60 s. The endogenous housekeeping gene 
GAPDH was served as an internal sample control. The sequence of the primers for the 
PCR ofGAPDH was 5’ TCC ACC ACC CTG TTG CTG TA, and 5，ACC ACA GTC 
CAT GCC ATC AC. The PCR product was separated in 2% agarose gel and stained 
with SYBR Green I for 20 min. The gel was subjected to Southem blotting after the 
photo was taken. 
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4.15 Probe labeling by PCR with DIG-dUTP 
For the PCR products of Dl & D2，D3 & D4，and D1 & D4，the probe was 
derived from the plasmid insert. The plasmid insert was digested with EcoR I, 
separated with agarose electrophoresis and recovered from the agarose gel as 
previously described. 10 ng of the insert DNA fragment was added to 50 pil of IX 
PCR buffer, 15 mM MgCl2, 2.5mM primers (DP#6 and UP#4), lx dNTP/DIG-dUTP 
mix (200 nM ofdATP, dCTP, and dGTP; 170 nM dTTP; 70 nM DIG-dUTP), 2 units 
of Taq.- PCR was performed on the thermal cycler (MJ Research) and the cycle 
protocol was 40 cycles ofadenaturation step at 94 °C for 60 s, an annealing step at 41 
°C for 60 s, and an extension step at 72 °C for 60 s. The PCR product was then 
purified with TE-100 column to remove the unincorporated nucleotide and primer 
dimer. The concentration of the PCR labeled probe was measured with OD260 
(Genequant II, Pharmacia Biotech). 
For the PCR product of GAPDH, gene specific internal probe was designed 
with the program OLIGO 4. The oligonucleotide was synthesized by Gibco BRL and 
the sequence of is as follows: 
5' TGA CAC GTT GGC AGT GGG GAC ACG GAA GGC 
The oligonucleotide was DIG labeled by DIG Oligonucleotide Tailing Kit 
(Boehringer Marmheim). The reaction mixture contained 50 pmole of 
oligonucleotide, 4 i^l tailing buffer (1 M potassium cacodylate, 0.125 M Tris-HCl, 
1.25 mg/ml bovine serum albumin, pH 6.6), 4 i^l 25 mM C0Cl2-s0luti0n, 1 ^1 1 mM 
DIG-dUTP, 1 i^l 0.3 mM dATP, and 50 units terminal transferase. The reaction 
mixture was incubated at 37°C for 15 min. 
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4.16 Southern blotting 
The PCR product was transferred to the nylon membrane by capillary 
transferring ovemight and fixed with UV crosslinking (Stratalinker 2400 UV 
Crosslinker, Stratagene). The 65cm^ membrane was prehybridized with 5ml of the 
hybridization buffer (5x SSC，1% blocking reagent, 0.1% N-lauroylsarcosine, 
0.02%SDS) at 68�C for an hour in a rotary oven. The solution will then be replaced 
with 5 ml ofhybridization buffer containing 150 ng of freshly heat-denatured labeled 
probe and incubated at 68°C for ovemight in an rotary oven. To reduce the 
background signal, the membrane was washed of 2 times of low stringency wash 
( 
solution (2x SSC, 0.1 % SDS) at room temperature for 5 min followed by 2 washes 
with high stringency wash solution (O.lx SSC, 0.1 % SDS) at 6 8 � C for 15 min. 
The membrane was used directly for immunological detection. First, the 
membrane was washed briefly in buffer 1 (150 mM NaCl, 100 mM Tris-HCl, 
pH=8.0) and then was incubated for 30 min with buffer X (1 % blocking reagent in 
buffer 1). After this, the solution was replaced with buffer X with anti-digoxigenin-
AP conjugate in the concentration 150 mU/ml and was incubated for another 30 min. 
The unbound antibody conjugate was removed by 2 times 15 min washes with buffer 
1. Then the membrane was equilibrated with buffer 2 (100 mM NaCl, 100 mM Tris-
HCl, 50 mM MgCl2, pH=9.5) for 2 min and the solution was then replaced with 
colour-substrate solution (45^il NBT, 35^il X-phosphate in 10 ml ofbuffer 2) for color 
development. Once the desired bands were detected, the reaction was stopped by 
washing the membrane for 5 min of buffer 3 (10 mM Tris-Hcl, 1 mM EDTA， 
pH=8.0). 
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Chapter 5: Results 
5.1 Clinical specimen 
The patient is a 7-year-old male who sustained a total body surface area 
(TBSA) 35 % the second or the third degree multiple site wax bum, involving face, 
shoulder, bilateral legs, and the left upper extremity. The hypertrophic scar tissue was 
obtained from the left elbow under routine hypertrophic scar excision on 5 months 
post-bum. The normal skin was obtained from the donor grafting site at left thigh. 
5.2 Primary explant culture 
The cells grew from the primary explants after culturing for 2 weeks. Usually, 
the polygonal keratinocytes grew prior to the fibroblasts. However, once the spindle 
fibroblasts appeared in the culture, they grew in a faster manner. The cells reached 
confluence after about one week of the first outgrowth. The typical confluent primary 
explant culture was shown in Figure 5.2.1. No significant difference in growth pattem 
and morphology was found between the hypertrophic scar fibroblasts (HSF) and the 
normal skin fibroblasts fN"F). 
After two passages, the fibroblasts overgrew the culture, and no polygonal 
shape keratinocyte could be detected by gross morphology. The homogeneity of the 
cells was confirmed by immuno-histochemical staining of the surface marker of the 
fibroblast (prolyl-4-hydroxylase), and compared with the immuno-histochemical 
staining of the surface marker of keratinocyte (keratin). The results were shown in 
Figure 5.2.2. All cells after two passages showed positive result for anti-prolyl-4-




Figure 5.2.1 Gross morphology of the confluent primary explant culture. 
T: the tissue explant. K: Cells with typical keratinocytes morphology - polygonal. F: 
Cells with typical fibroblasts morphology - biopolar, spindle, and form parallel 
arrays. (Phase contrast, 100 X) 
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Figure 5.2.2 Immuno-histochemical staining of the cultured cells after 2 
passages. (A) Cells were stained by anti-keratin, and showed negative result in all 
fields. (B) Cells were stained by anti-prolyl-4-hydroxylase, and showed positive result 
in all fields. (Light microscope, 300 X) 
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5.3 Total RNA extraction from the cultured fibroblasts 
The yield of the total RNA from the confluent fibroblasts in a 75cm^ flask was 
about 80 ^ig. The ratio of OD260 /OD280 of the total RNA was >1.6. The total RNA 
was then digested with RNase-free DNase I. The integrity and the purity of the total 
RNA was analyzed by 0.8 % native agarose gel electrophoresis, and the result is 
shown in Figure 5.3.1. One microgram of the total RNA sample was loaded on each 
lane. A very faint high-molecular weight genomic DNA band could be detected 
before DNase I digestion. No DNA could be detected after DNase digestion. For all 
total RNA samples, the intensity of 28S was approximately double to 18S, and no 
smear was detected between 18S and 5S. 
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Figure 5.3.1 Electrophoresis analysis (0.8% agarose gel) of the total RNA 
before (A) and after DNase I digestion (B). 
* : high molecular weight genomic DNA could be detected before DNase I digestion. 
Lane 1 and 3: total RNA from HSF，Lane 2 and 4: total RNA from the NF. For each 
sample, approximately 1 i^g of total RNA was loaded. 
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5.4 Differential display RT-PCR 
DDRT-PCR products with the primer combinations DP#9 and UP#l-12 were 
displayed on a 6% non-denaturing polyacrylamide gel. DDRT-PCR products with 
primer combinations DP#6-8 and UP#l-12 were displayed on a GEL-MIX 6 denature 
polyacrylamide gel. All samples were run in duplicate. Only the cDNA fragments 
differentially expressed in duplicate were regarded as positive results. 3 differentially 
expressed bands were identified, and the result is shown in Figure 5.4.1. B1 was 
amplified with primers DP#9 & U P # l and was up-regulated in HSF. B2 was 
amplified with primers DP#7 & UP#3, and was up-regulated in HSF. B3 was 
amplified with primers DP# 6 & UP#4, and was down-regulated in HSF. 
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Figure 5.4.1 Autoradiograph of the differential display gels. Three differentially 
expressed bands were identified by polyacrylamide gel electrophoresis. Panel A: B1 
was amplified with DP#9 & UP#2，and was up-regulated in hypertrophic scar 
samples. The cDNA fragments of panel A were separated in 6% non-denature 
polyacrylamide gel. Panel B: B2 was amplified with DP#7 & UP#3, and was up-
regulated in hypertrophic scar samples. The cDNA fragments were separated in GEL-
MIX-6 denature polyacrylamide gel. Panel C: B3 was amplified with DP#6 & UP#4, 
and was down-regulated in hypertrophic scar samples. The cDNA fragments of panel 
B and C were separated in GEL-MIX-6 denature polyacrylamide gel. 
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5.5 Reamplification of the DNA fragments 
B3 was chosen to be further investigated because it exhibited most dramatic 
difference between HSF and NF. The NF side and HSF side ofB3 were separately cut 
from the dried gel. In order to confirm these bands were cut precisely, additional 
autoradiograph was performed on the gel after the desired band was excised from the 
gel. The comparison of the gel before and after excision was shown in Figure 5.5.1. 
The result showed that these bands were cut precisely from the gel. 
These excised bands were then reamplified by PCR with the primers DP#6 
and UP#4. The PCR products were analyzed by 1.5 % agarose gel, and the result was 
shown in Figure 5.5.2. Two bands Q^\ and N2) were found in NF sample. The size of 
the smaller band N1 was about 200 bp, and the size of the larger band N2 was about 
360 bp. On the other hand, only one band (S1) was detected in the HSF sample, and 
the size of S1 was about 200 bp, which was similar to N1. These bands S1, N1 and 
N2 were excised and extracted from the agarose gel, and reamplified by another PCR 
with the same primer sets DP#6 & UP#4. The products were analyzed by 1.5 % 
agarose electrophoresis, and the result was shown in Figure 5.5.3. One band with 
expected size was detected in each reamplification reaction. 
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Figure 5.5.1 Autoradiographs of the polyacrylamide gel containing cDNA 
fragment B3. (A) before excision (B) after excision. The autoradiograph of the gel 
after excision showed discrete cut edge in the position of B3. Both flhns were 
exposed for 48 hours. 
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Figure 5.5.2 Electrophoresis analysis (1.5 % agarose gel) of the reamplif!cation 
PCR products from B3. Lane 1: extracted DNA fragment from the NF side of B3 
was added to the PCR as the template, and 2 bands were shown. The smaller DNA 
fragment Q^l) was about 200 bp in size, and the larger DNA fragment ^Sf2) was about 
360 bp in size. Lane 2: extracted DNA fragment from the HSF side was added to the 
PCR as the template, and a discrete band about 200 bp in size was shown. Lane M: 1 
kb ladder marker. The gel was stained with SYBR Green I for 20 min 
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Figure 5.5.3 Electrophoresis analysis (1.5% agarose gel) of the reamplification 
PCR products from fragments S1, N1 and N2. Lane 1: negative control; water was 
added to the PCR reaction as the template instead of the extracted DNA. No band 
could be found. Lane 2: extracted DNA from S1 was added to the PCR as the 
template, and a discrete band about 200 bp in size was shown. Lane 3: extracted 
DNA from N1 was added to the PCR reaction as template, and a discrete band of 
about 200 bp was shown. Lane 4: extracted DNA from N2 was added to the PCR 
reaction as template, and a discrete band of about 360 bp was shown. Lane M: 1 kb 
ladder marker. The gel was stained with SYBR Green I for 20 min. 
4 . 
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5.6 Molecular cloning of the DNA fragments 
The DNA fragments Nl，N2 and S1 and the positive control supplied from the 
kit were subcloned into the pCR2.1 vector, and transformed into the E.coli D5oc. For 
the positive control, three white colonies were randomly picked from the LB agar 
plates. For the samples S1, Nl , and N2, twelve white or pale blue colonies were 
randomly picked form the agar plate. These colonies were grown in LB medium 
ovemight. All colonies from S1 and the positive control were successfully grown. 
However, only 11 colonies from Nl and 9 clones from N2 were successfully grown. 
The plasmid DNA samples were extracted from these colonies, and were digested 
with EcoR[. The digested DNA fragments were analyzed by 1% agarose gel 
electrophoresis and the results of S1, Nl , N2 and the positive control were shown in 
Figures 5.6.1, 5.6.2, 5.6.3 and 5.6.4 respectively. 
For S1, two clones contained the inserts but only one of these inserts had 
expected size (about 200 bp). For Nl , three clones contained inserts, and all of these 
inserts had expected size (about 200 bp). For N2, three clones contained inserts and 
all of these inserts had expected size (about 400 bp). Clone 5 ofN2 resisted to EcoR I 
digestion. 
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Figure 5.6.1 Electrophoresis analysis (1% agarose gel) of EcoKl digested 
plasmids from S1. Lane 1-12: Plasmids from the 12 colonies of S1 were digested 
with EcoR I. Lane 7 contained an insert with expected size (about 200 bp). Lane 10 
contained an insert but not with expected size. Lane M: 1 kb ladder marker. The gel 
was stained with SYBR Green I for 20 min. 
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Figure 5.6.2 Electrophoresis analysis (1% agarose gel) of EcoKl digested 
plasmids from N1. Lane 1-11: Plasmids from the 11 colonies o f N l was digested 
with EcoR I. Lane 6, 7, 9 contained inserts with expected size (about 200 bp). Lane 
M: 1 kb ladder marker. The gel was stained with SYBR Green I for 20 min. 
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Figure 5.6.3 Electrophoresis analysis (1% agarose gel) of EcoRl digested 
plasmids from N2. Lane 1-9: Plasmids from the 9 colonies o fN2 were digested with 
EcoR 1. Lane 2, 3, and 9 contained insets with expected size (about 400 bp). Lane 5: 
the plasmid was resisted to EcoR I digestion. Lane M: 1 kb ladder marker. The gel 
was stained with SYBR Green I for 20 min. 
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Figure 5.6.4 Electrophoresis analysis (1% agarose gel) of EcoKl digested 
plasmids from the positive control. Lane 1-3: Plasmids from the 3 colonies of the 
positive control from supplier were digested with EcoR I. All lanes 1-3 contained 
inserts with expected size (about 700 bp). Lane M: 1 kb ladder marker. The gel was 
stained with SYBR Green I for 20 min. 
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5.7 DNA sequencing of the inserts 
Plasmids from clone 7 o fS l , clone 6 o f N l and clone 3 o fN2 were sequenced. 
dsDNA cycle sequencing system (Gibco, BRL) was applied at first to sequence the 
plasmids. However, we found that not more than 300 bp of sequence could be read， 
and ambiguous sequences were detected. Therefore, custom sequencing service 
provided from Oswel laboratory was employed to sequence the inserts. The sequences 
of the S1, N1, and N2 were shown in Figure 5.7.1, 5.7.2, and 5.7.3 respectively. The 
total length of the S1, N1 and N2 inserts were 205 bp, 204 bp and 358 bp respectively. 
• 
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1 GATCGCATTG GATGGCACTT AAAATTGTTT TCTGGTTGAA 4 0 
4 1 AATATTTCTC ATGAGAAGAA AGCAAAAAAT AATTCCCTGA 80 
8 1 CACTGTATTT TATGAAATTT CTATGGCTTT TTTTTTTTTT 1 2 0 
1 2 1 CGGTGGAAAA TAACTTTTAT TGAGACCCCA CCAACTGCAA 1 6 0 
1 6 1 AATCTGTTCC TGGCATTAAG CTCCTTCTTC CTTTGCAATG 2 0 0 
2 0 1 CGATC 2 0 5 
Figure 5.7.1 The sequence of S1. The total length of the insert is 205 bp. Sequence 
in blue fonts is identical to the upstream primer #4. Sequence in red fonts is identical 
to the downstream primer #6. Sequence in green fonts is the polyadenylation signal of 
the mRNA 3，end. 
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1 GATCGCATTG CAAAGGAAGA AGGAGCTTAA TGCCAGGAAC 4 0 
4 1 AGATTTTGCA GTTGGTGGGG TCTCAATAAA AGTTATTTTC 80 
8 1 CACCGAAAAA AAAAAAAAAG TTACAAAATT CCATCAAAGA 1 2 0 
1 2 1 CAGATACACA GTATAAATCG TTAGGTGAAC ACAGAAGGTT 1 6 0 
f � 
1 6 1 GGTCTCATCT CCTGATTGTT GTCACAGGTA TCTCCAATGC 2 0 0 
2 0 1 GATC 2 0 4 
Figure 5.7.2 The sequence of N1. The length of the insert is 204 bp. Sequence in 
blue fonts is identical to the upstream primer UP#4. Sequence in red fonts is identical 
to the downstream primer #6. Sequence in green fonts is the polyadenylation signal of 
the mRNA 3, end. 
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1 GATCGCATTG GAGATACCTG TGACAACAAT CAGGATATTG 4 0 
4 1 ATGAAGATGG CCACCAGAAC AATCTGGACA ACTGTCCCTA 80 
8 1 TGTGCCCAAT GCCAACCAGG CTGACCATGA CAAAGATGGC 1 2 0 
1 2 1 AAGGAAAGGC TGTGGCCACC TGATGACCCT TTCCCTTTTT 1 6 0 
1 6 1 TTTTTCGGAT TCACCTCACT TTTATTATGA ACAAACACAA 2 0 0 
2 0 1 TCTCAGATTA GTACAATTAG CTTCAGAGTT GATATTAATA 2 4 0 
2 4 1 GAAATTATTC CAAAATTATT CCTGTCACAA GTAACTACTA 2 8 0 
2 8 1 TATCCCACAT AAAAAGGGAA AAAATCCCAC CCAATCACAG 3 2 0 
3 2 1 AAAAGGCATC CTCTGTATGT TTCCGTGGCA ATGCGATC 3 5 8 
Figure 5.7.3 The sequence of N2. The total length of the insert is 358 bp. 
Sequence in blue fonts is identical to the upstream primer #4. Sequence in red fonts is 
identical to the downstream primer #6. Sequence in green fonts is the polyadenylation 
signal ofthe mRNA 3, end. 
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5.8 Analysis and identification of the DNA sequences 
The sequences of S1, N1 and N2 were submitted to Web-Cutter 2.0 for 
analysis ofthe restriction site, and the results were shown in Figures 5.8.1, 5.8.2, and 
5.8.3 respectively. Summary of the restriction sites of S1, N1, and N2 were shown in 
Tables 5.8.1, 5.8.2, and 5.8.3 respectively. 
The sequences were submitted to BLASTS to compare the known genes or 
EST sequence in Genbank databases. The results showed that S1 and N1 exhibited 
significant homology with the 3, end of human ribosomal protein L3 mRNA. N2 
exhibited significant homology with the 3'end of cytochrome b561 mRNA and 
thrombospondin 1 mRNA. The summary of the results of the nucleic acid homology 
search with BLASTS o fS l , N1 and N2 were shown in Figures 5.8.4, 5.8.5, and 5.8.6 
respectively. 
The nucleic acid sequences o fS l , N1, and N2 were also submitted to the open 
reading frame analysis to find the corresponding amino acid sequences, and the 
summary of the results was shown in Tables 5.8.4, 5.8.5 and 5.8.6 respectively. The 
amino acid sequences were submitted to BLASTS to compare the known protein in 
Genbank databases. However, only the +1 open reading frame of N2 exhibited 
significant homology with the known amino acid sequence thrombospondin 1. The 
summary of the result of the amino acid homology search with BLASTS of +1 open 
reading frame ofN2 was shown in Figure 5.8.7. 
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SspI BspHI 








151 Ccaactgcaaaatctgttcctggcattaagctccttcttcctttgcaatgcgatc 205 
Ggttgacgttttagacaaggaccgtaattcgaggaagaaggaaacgttacgctag 
Figure 5.8.1 The restriction map ofthe S1. 
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Table 5.8.1 The summary of the restriction sites of S1. 
Enzyme No. Positions Recognition 
name cuts of sites sequence 
AcsI 1 95 r/aatty 
ApoI 1 95 r/aatty 
BsaI 1 147 ggtctc 
BspHI 1 4 9 t/catga 
BsrDI 1 2 00 gcaatg 
Eco31I 1 147 ggtctc 
RcaI 1 49 t/catga 
SspI 1 43 aat/att 
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BsrDI Eco31I 








151 Acagaaggttggtctcatctcctgattgttgtcacaggtatctccaatgcgatc 204 
Tgtcttccaaccagagtagaggactaacaacagtgtccatagaggttacgctag 
BsaI 
Figure 5.8.2 The restriction map of N1. 
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Table 5.8.1 The summary of the restriction sites of S1. 
Enzyme No. Positions Recognition 
name cuts of sites sequence 
AcsI 1 106 r/aatty 
ApoI 1 106 r/aatty 
BsaI 2 64 166 ggtctc 
BsrDI 1 11 gcaatg 
Eco31I 2 64 166 ggtctc 
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Table 5.8.1 The summary of the restriction sites of S1. 
Enzyme No. Positions Recognition 
name cuts of sites sequence 
AseI 1 235 at/taat 
AsnI 1 235 at/taat 
Asp700I 1 245 gaann/nnttc 
Ball 2 50, 135 tgg/cca 
BglI 1 97 gccnnnn/nggc 
BsrDI 1 353 gcaatg 
BstDSI 1 343 c/crygg 
CfrI 2 48, 133 y/ggccr 
DsaI 1 343 c/crygg 
EaeI 2 48, 133 y/ggccr 
Eco57I 1 226 ctgaag 
MluNI 2 50, 135 tgg/cca 
MscI 2 50, 135 tgg/cca 
PshAI 1 71 gacnn/nngtc 
PshBI 1 235 at/taat 
VspI 1 235 at/taat 
XcmI 1 112 ccannnnn/nnnntgg 
XmnI 1 245 gaann/nnttc 
68 
Gene Gene bank code Score E Identities 
(bits) value 
Human ribosomal protein L3, gbM90054/ 1 ^ le-35~~~77/77 
mRNA, 3'end HUMRRL3A (100%) 
gb|M90054|HUMRRL3A Human ribosomal protein L3 mRNA, 3‘ end. 
Query: 123 qtggaaaataacttttattqagaccccaccaactgcaaaatctgttcctggcattaaqct 182 
l ^ T ( m m m m m l ^ l ^ i m m i m h m m l ^ i m r f m m T i i 
Sbjct: 1251 gtggaaaataacttttattgagaccccaccaactgcaaaatctgttcctggcattaagct 1192 
Query: 183 ccttcttcctttgcaat 199 
IIIIIIIIIIIIIIIII Sbjct: 1191 ccttcttcctttgcaat 1175 
Figure 5.8.4 S1 exhibited significant homology with human ribosomal protein 
L3. Sequence in green fonts showed the polyadenylation signal of the mRNA 3, end. 
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Gene Gene bank code Score E Identities 
(bits) value 
Human ribosomal protein L3, gbM90054/ i ^ le-35~~77/77 
mRNA, 3'end HUMRRL3A (100%) 
gb|M90054|HUMRRL3A Human ribosomal protein L3 mRNA, 3‘ end. 
Query: 7 竹|竹竹|竹||〒||竹|冗1竹|竹打|行||||竹^〒^|：^ 竹^|打"^竹^竹竹|行||| 66 
Sbjct: 1175 attgcaaaggaagaaggagcttaatgccaggaacagattttgcagttggtggggtctcaa 1234 
Query: 67 taaaagttattttccac 83 
l l i l l l l l i l l l l l l l l Sbjct: 1235 taaaagttattttccac 1251 
Figure 5.8.5 N1 exhibited significant homology with human ribosomal protein 
L3. Sequence in green fonts showed the polyadenylation signal of the mRNA 3，end. 
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Gene Gene bank code Score E Identities 
(bits) value 
Human~~cytochrome~~B561 gb/U06715/ m 3e-77~~174/179 
(HCYTO B561), mRNA HSU06715 (97%) 
Human mRNA for Emb/X04665/ 240 le-76 121/121 
thrombospondin HSTHROMR (100%) 
gb|U06715|HSU06715 Human cytochrome B56l, HCYTO B561, mRNA, partial cds. 
Query: 168 qattcacctcacttttattatgaacaaacacaatctc-agatta-gtacaattagcttca 225 
l l l l l l l l l l l l l l l l l l l l ] l l l l l l l l l l l l l l l Mllll IIMIIMMIMM 
Sbjct: 2641 gattcacttcacttttattatgaacaaacacaatctcgagattatgtacaattagcttca 2582 
Querv: 226 qaqttqatattaataqaaattattccaaaattattcctqtcacaagtaactactatatcc 285 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 1川丨1丨丨川1丨丨丨1丨丨丨丨丨 I 
Sbjct: 2581 gagttgatattaatagaaattattccaaaattattcttgtcacaagtaactactatat-c 2523 
Query: 286 cacataaaaaqqqaaaaaatcccacccaatcacagaaaaggcatcctctgtatgtttcc 344 
1丨丨丨丨丨丨11_丨丨丨丨丨|111丨丨丨丨||丨丨丨||化||打丨丨丨丨|||丨1^丨丨1丨丨丨丨| 
Sbjct: 2522 cacataaaaagggaaaaaatcccacccaatcacagaaaaggcatcctctgtatgtttcc 2464 
emb|X04665|HSTHROMR Human mRNA for thrombospondin 
Query: 4 cqcattqqaqatacctgtgacaacaatcaggatattgatgaagatggccaccagaacaat 63 
iT imniTmi i iT iT immi i in i iml^ i l ^ iYi in i i i i i iY i i i i i i 
Sbjct: 2626 cgcattggagatacctgtgacaacaatcaggatattgatgaagatggccaccagaacaat 2685 
Query: 64 ctggacaactgtccctatgtgcccaatgccaaccaggctgaccatgacaaagatggcaag 123 
1丨打丨丨丨1丨|7丨丨丨丨丨丨丨1^1^1丨11|7丨1丨丨丨丨1打1|1^丨丨丨丨丫丨丨丨1丨丫丨1丫丫丨丨丨丫 Sbjct: 2686 ctggacaactgtccctatgtgcccaatgccaaccaggctgaccatgacaaagatggcaag 2745 
Query: 124 y 124 
Sbjct: 2746 g 2746 
Figure 5.8.6 N2 exhibited significant homology with human cytochrome b561 
and thrombospondin. Sequence in green fonts showed the polyadenylation signal of 
the mRNA 3, end. 
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Table 5.8.4. All open reading frames of S1. 











一 3 SHCKGRRSLMPGTDFAVGGVSIKVIFHRKKKKAIEIS*NTVSGNYFLLSSHEKYFQPENN 
FKCHPMRX 
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Table 5.8.5. All open reading frames ofNl. 














Tabie 5.8.6. All open reading frames ofN2. 




L *TNT 工 SD*YN*LQS*Y** KLFQNYSCHK*LLYPT*KGKKSHPITEKASSVCFRGNAI 
+3 SHWRYL*QQSGY**RWPPEQSGQLSLCAQCQPG*P*QRWQGKAVAT**PFPFFFSDSPHFY 
YEQTQSQISTISFRVDINRNYSKIIPVTSNYYIPHKKGKNPTQSQKRHPLYVSVAMRX 







Gene Score (bits) E value Identities 
Human thrombospondin 1 (TSP 1) 98.3 2 ^ 43/49 (87%) 
precursor 
sp IP07996 ITSPl_HUMAN THROMBOSPONDIN 1 PRECURSOR 
Query: 1 DRIGDTCDNNQDIDEDGHQNNLDNCPYVPNANQADHDKDGKERLWPPDD 49 
DRIGDTCDNNQDIDEDGHQNNLDNCPYVPNANQADHDKDGK DD 
Sbjct: 850 DRIGDTCDNNQDIDEDGHQNNLDNCPYVPNANQADHDKDGKGDACDHDD 898 
Figure 5.8.7 Amino acid sequence of +1 open reading frame of N2 exhibited 
significant homology with human thrombospondin 1 precursor. 
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5.9 Semi-quantitative RT-PCR analysis of the differentially 
expressed genes 
The BLASTS analysis showed that both bands N1 and S1 shared homology 
with the ribosomal protein L3. On the other hand, the band N2，which only been seen 
in HF samples, shared homology with the gene thrombospondin 1 and cytochrome 
b561. Therefore, N2 was suspected to be the true differentially expressed product. 
Four primers were designed to perform semi-quantitative RT-PCR. The 
strategy of the primer designed was shown in Figure 5.9.1. The sequence and Tm of 
each primer were listed in Table 5.9.1. The expected PCR product sizes of different 
primer combinations were listed in Table 5.9.2. 
The RT-PCR products were analyzed with agarose gel electrophoresis and 
Southern blot with DIG-labeled probe. The result of RT-PCR with primer 
combination D1 & D4 was shown in Figure. 5.9.2. No signal could be detected by 
Southern blot neither in NF nor in HSF (Figure 5.9.2B). 
The result ofRT-PCR with primer combination D3 & D4, which were specific 
to human thrombospondin 1 gene, was shown in Figure. 5.9.3. The result of Southern 
blot showed that the expression of thrombospondin in the HSF sample was lower than 
that in the NF (Figure 5.9.3B). 
The result ofRT-PCR of primer combination D1 & D2, which were specific to 
the human cytochrome b561 gene, was shown in Figure. 5.9.4. The result of Southern 
blot showed that the expression of cytochrome in HSF sample was also lower than 
that in the NF (Figure 5.9.4B). 
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The RT-PCR result of the internal control GAPDH was showed in 
Figure.5.9.5. The result of Southern blot showed that the expression of GAPDH in 
HSF and NF had no significant difference (Figure 5.9.5B). 
For all ofthese RT-PCR analysis, the negative control were received the 
identical procedures as the experimental group but only omitted the reverse 
transcriptase in the procedure of reverse transcription. All of the negative control 




GATCG CATTG GAGAT ACCTG TGACA ACAAT CAGGA TATTG ATGAA GATGG 1-50 bp 
CTAGC GTAAC CTCTA TGGAC ACTGT TGTTA GTCCT ATAAC TACTT CTACC 
CCACC AGAAC AATCT GGACA ACTGT CCCTA TGTGC CCAAT GCCAA CCAGG 51-100 bp 
GGTGG TCTTG TTAGA CCTGT TGACA GGGAT ACACG GGTTA CGGTT GGTCC 
< D3 
CTGAC CATGA CAAAG ATGGC AAGGA AAGGC TGTGG CCACC TGATG ACCCT 101-150 bp 
GACTG GTACT GTTTC TACCG TTCCT TTCCG ACACC GGTGG ACTAC TGGGA 
TTCCC TTTTT TTTTT CGGAT TCACC TCACT TTTAT TATGA ACAAA CACAA 151-200 bp 
AAGGG AAAAA AAAAA GCCTA AGTGG AGTGA AAATA ATACT TGTTT GTGTT 
TCTCA GATTA GTACA ATTAG CTTCA GAGTT GATAT TAATA GAAAT TATTC 201-250 bp 
AGAGT CTAAT CATGT TAATC GAAGT CTCAA CTATA ATTAT CTTTA ATAAG 
D2 • 
CAAAA TTATT CCTGT CACAA GTAAC TACTA TATCC CACAT AAAAA GGGAA 251-300 bp 
GTTTT AATAA GGACA GTGTT CATTG ATGAT ATAGG GTGTA TTTTT CCCTT 
AAAAT CCCAC CCAAT CACAG AAAAG GCATC CTCTG TATGT TTCCG TGGCA 301-350 bp 
TTTTA GGGTG GGTTA GTGTC TTTTC CGTAG GAGAC ATACA AAGGC ACCGT 
ATGCG ATC 351-358 bp 
TACGC TAG 
< D1 
Figure 5.9.1 Primers designed for RT-PCR. D1 and D2 are specific to 
cytochrome b561. D3 and D4 are specific to thrombospondin 1. 
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Table 5.9.1 The sequence and calculated Tm ofthe primers 
Primer Sequence T；^  Homology in genbank 
no. 
~ m 5’ GAG GAT GCC TTT TCT GTG AT 58.0 °C~~gb/U06715/HSU06715 
Human cytochrome B561, 
mRNA (2453-2434) 
D2 5，TAT TAT GAA CAA ACA CAA TCT C 56.5 °C gb/ U06715/ HSU06715 
Human cytochrome B561, 
mRNA, partial cds (2656-2677) 
D3 5’ CAT CTT TGT CAT GGT CAG CC 62.1�C emb/ X04665/ HSTHROMR 
Human mRNA for 
thrombospondin (2740-2721) 
D4 5，CGC ATT GGA GAT ACC TGT GA 62.9 'C emb/ X04665/ HSTHROMR 
Human mRNA for 
thrombospondin (2626-2645) 
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Table 5.9.2 The expected size of the PCR products by different primer 
combinations. 
Primers Corresponding Expected size of 
combination gene the PCR product 
D1, D2 Human cytochrome 151 bp 
B561 
D3,D4 Human 115bp 
thrombospondin 1 
Dl ,D4 Unknown 330bp 
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1 2 3 , 
a b c 
^ ^ ^ ^ ^ ^ H 
^ ^ ^ M j m 
^ ^ ^ ^ ^ ^ ^ ^ 330bp ^ ^ t 330bp 
35 cycles 35 cycles 
Figure 5.9.2 RT-PCR with the primer combination D1 & D4. A: Electrophoresis 
analysis (1.5% agarose gel) of the 35 cycles RT-PCR products. B: The DNA 
fragments were Southern transferred to a positively charged nylon membrane and 
hybridized with DIG labeled plasmid insert N2. Lane 3 and c: RT-PCR product from 
the N2 plasmid. Lane 1 and a: RT-PCR product from NF cDNA. Though it showed 
similar size as the positive control, no signal could be detect after hybridization. Lane 
2 and b: RT-PCR product from HSF cDNA. No size match product was found and no 
signal could be detected after hybridization too. 
81 
A B 
1 2 3 4 a b c d 
II 
^^^^^H ^^^^^H ^^^ i^ i^H||^ . 
^ ^ H ^ ^ H ^ 1 1 3 bp flP . flHi — 1 1 3 bp 
10 15 10 15 
cycles cycles cycles cycles 
Figure 5.9.3 Thrombospondin 1 (TSP 1) expression in NF and HSF. cDNA form 
NF and HSF were amplified by the primer combination D3 & D4. A: Electrophoresis 
analysis (2% agarose gel) of the RT-PCR products. B: The DNA fragments were 
Southern transferred to a positively charged nylon membrane and hybridized with 
DIG labeled plasmid insert N2. Lane 1, 2 and a, b: 10 cycles of PCR was performed. 
Lane 3, 4 and c, d: 15 cycles of PCR was performed. Lane 1, 3 and a，c: RT-PCR 
product ofNF cDNA. Lane 2, 4 and b，d: RT-PCR product ofHSF cDNA. 
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A B 
1 2 3 4 a b c d 
II 
^ ^ H ^ ^ H ( ^^—131 bp 
10 15 10 15 
cycles cycles cycles cycles 
Figure 5.9.4 Cytochrome b561 expression in NF and HSF. cDNA from NF and 
HSF were amplified by primer combination D1 & D2. A: Electrophoresis analysis 
(2% agarose gel) of the RT-PCR products. B: The DNA fragments were Southern 
transferred to a positively charged nylon membrane and hybridized with DIG labeled 
plasmid insert N2. Lane 1，2 and a, b: 10 cycles ofPCR was performed. Lane 3，4 and 
c, d: 15 cycles of PCR was performed. Lane 1, 3 and a, c: RT-PCR product o f N F 
cDNA. Lane 2, 4 and b, d: RT-PCR product ofHSF cDNA. 
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A B 
1 2 a b c d 
I ..-
^ ^ ^ ^ ^ 1 ^ W ^ ^ 
^ ^ 3 
15 10 15 
cycles cycles cycles 
Figure 5.9.5 GAPDH expression in NF and HSF. A: Electrophoresis analysis (2% 
agarose gel) of the RT-PCR products. B: The DNA fragments were Southern 
transferred to a positively charged nylon membrane and hybridized with DIG labeled 
internal sequence oligonucleotide. Lane a, b: 10 cycles of PCR was performed. Lane 
1，2 and c, d: 15 cycles of PCR was performed. Lane 1 and a, c: RT-PCR product of 
NF cDNA. Lane 2 and b, d: RT-PCR product ofHSF cDNA. 
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Chapter 6: Discussion 
Part I Validity of the findings 
6.1 Tissue sampling 
Hypertrophic scar has been regarded as a serious clinical problem for a long 
time. The major limitation in study of the pathogenesis ofhypertrophic scar is that no 
animal model available (Rockwell et aL, 1989). Studies on hypertrophic scar relied 
totally dn clinical specimens from the patients. Yet studies posed queries on the 
validity of comparison of hypertrophic scar with normotrophic scar or normal skin 
from different patients (Ghahary et aL, 1995). 
Hypertrophic scar is regard as a deviation of wound healing. To understand 
this deviation, comparing hypertrophic scar to the normotrophic scar is theoretically 
essential apart from comparing hypertrophic scar to normotrophic scar. Yet with 
ethical concern, it is impossible for us to obtain the normotrophic scar and 
hypertrophic scar from the same patient. 
Moreover, although the histology and the tensile strength of normal skin and 
normal scar are not entirely identical. The gene expressions and biological behaviors 
of the fibroblasts in normal skin and normotrophic scar do not show any significant 
difference (Castagnoli et aL, 1993，Messadi and Bertolami, 1993). That is why most 
ofthe studies employ the normal skin fi:om the same patient as a control to investigate 
the gene alteration (Ghahary et aL 1993，Ghahary et al., 1995) and the same approach 
is adopted in the present study. 
85 
6.2 Tissue culture model 
Primary explant culture technique was first described by Harrison (1907) and 
Carrel (1912). This is a widely acceptable model to investigate the properties of 
hypertrophic scar fibroblasts to date (Diegelmann et al., 1979，Ghahary et al., 1993, 
Wassermann et aL, 1998). 
In the present study, this system was chosen and successfully established. To 
eliminate the effect of variables such as age, sex, race or even individual response to 
thermal injury, normal skin from the same patient was employed as control. Like 
other hypertrophic scar studies, we are not able to eliminate the effect of wound 
\ 
I 
location in the hypertrophic scar formation. 
There is no consensus amongst different studies on the passage number ofthis 
model, with number ranging from three to eight (Grahary et al., 1993, Carol et al., 
1996). Grahary et a.l. (1995) pointed out that the passage number has a marked effect 
on the gene expression of the fibroblasts, and the cells may lose their specialized 
properties in continuous proliferation through de-differentiation. Therefore, the third 
passage cells were chosen in present study to minimize the risk of de-differentiation. 
Nevertheless, we still cannot ignore this possibility, as the consensus marker of 
hypertrophic scar fibroblasts has not been identified yet. 
The homogeneity of the fibroblast culture is a crucial factor in interpreting the 
results of DD-RTPCR because false positive results can be arisen from any 
contaminating cell type. As the human skin is a very complicated organ and consists 
of various cell types, it was not surprised to find other cell types in our primary 
explant culture. We identified keratinocytes as the most seriously contaminated cell 
type in the primary culture by gross morphology (Figure 5.2.1). In contrast, this cell 
type was confirmed to be totally absent after 2 passages using immuno-histochemical 
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staining of keratinocyte surface marker (Figure 5.2.2 A). The homogeneity of the 
fibroblasts culture was further confirmed by irrunno-histochemical staining using 
fibroblast surface marker (Figure 5.2.2 B). These findings supported that the culture 
was free from keratinocytes contamination, and the homogeneity of the fibroblasts 
was high enough for DDRT-PCR. 
6.3 Differential display RT-PCR 
6.3.1 Identification of the differentially expressed genes 
Obtaining undegraded mRNA that is free of DNA contamination as the 
\ 
1 
starting material is a critical starting step in producing high quality differential display 
gels (Liang & Pardee, 1995). Degraded mRNA and genomic DNA contamination are 
the main sources to generate false positive bands. 
In the present study, the electrophoresis of the total RNA (Figure 5.3.1) 
showed that the 28S rRNA was about two times that o f l8S rRNA, and no smear was 
found between the low molecular weight 5S tRNA and 18S rRNA. In addition, the 
OD260/ OD280 ratio of the RNA was greater than 1.6. These results suggested that 
the isolated RNA had no significant degradation and the quality of the RNA was 
suitable for DDRT-PCR. 
The original protocol of differential display by Bauer et aL. (1993) estimated 
that a combination of 12 downstream primers (T1 lVN: where V can be A，G，or C， 
and N can be any of the four nucleotides) and 26 arbitrary upstream primers would 
cover about 95% of the expressed gene. In present study, we start to use 4 anchored 
oligo-(dT) downstream primers and 12 arbitrary upstream primers to compare the 
gene expression in human fibroblasts from the hypertrophic scar and normal skin. 
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Other primer combinations will be performed at further study to generate a more 
complete pattem of the mRNA expression. 
In the beginning of the present study, nondenaturing polyacrylamide gel 
electrophoresis was used to separate the DDRT-PCR product. Nevertheless the 
/ 
resolution of the gels was low (Figure 5.4.1, panel A), especially when analyzing the 
high molecular weight bands. We employed GEL-MIX 6 denaturing polyacrylamide 
gel at the latter stage of our study in order to obtain higher resolution when analyzing 
the amplified cDNA fragments. 
Patterns of amplified cDNA fragments from HSF and NF were largely 
\ 
identical, and they provided a reproducible uniform background over which specific 
differences could be observed (Figure 5.4.1). Three differentially expressed bands B1, 
B2 and B3 were identified in the differential display gel. B3, which was down-
regulated in HSF, was chosen to be characterized further because the difference 
between the HSF and NF expression was the most dramatic. After reamplification by 
the same pair of primers as DDRT-PCR, there were two fragments ^Sfl and N2) 
identified in the NF and one fragment (S1) identified in HSF (Figure 5.5.2). These 
findings proved that B3 contained more than one DNA fragment. 
After cloning and sequencing these three cDNA fragments it was surprise to 
find that all the fragments had identical sequence as the upstream primer at both 
terminals, and the anchored TuCG was found somewhere in the middle of the 
fragments (Figures 5.7.1, 5.7.2，5.7.3). This is different to the typical DDRT-PCR 
product, which has an anchored oligo-(dT) at one terminal and an arbitrary primer at 
the other. Although these are not the typical DDRT-PCR products, similar results 
were also reported by other groups (Momiyama et al., 1995, Guimaraes et al., 1995, 
Nitsche et al., 1996，Zhang et al., 1998). 
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Both N1 and S1 showed high homology to the 3'end of human ribosomal 
protein L3 mRNA and polyadenylation signal AATAAA was found 15 bp upstream 
from the multiple adenylate site (Figure 5.8.4, Figure 5.8.5). On the other hand, both 
fragments also have anonymous sequence which do not show significant homology to 
any known gene or EST. N2 showed high homology to the 3’ end of human 
cytochrome b561 and thrombospondin 1 (Figure 5.8.6). All these findings supported 
that the band B3 from the polyacrylamide gel should have contained more than one 
cDNA fragment. 
« 
6.3.2 Confirmation of the differentially expressed genes 
The differential expression of thrombospondin 1 and cytochrome b561 in NF 
and HSF was further investigated by semi-quantitative RT-PCR. Although Northern 
blot analysis is the golden standard to study mRNA expression, semi-quantitative RT-
PCR was chosen to investigate the mRNA expression of these differentially expressed 
genes in this study. The advantages of semi-quantitative RT-PCR are capable to 
detect low abundant class of mRNA, and require small amount of RNA. This method 
is suitable for our model as only limit amount of total RNA can be obtained from each 
cell strain. 
Numerous bands were detected by SYBR Green I staining after 35 cycles RT-
PCR amplification in NF and HSF (Figure 5.9.2 A) with the primer combination D1 
& D4. However, these bands were proved to be non-specific PCR products after 
Southern blot confirmation (Figure 5.9.3 B). 
On the other hand, gene specific RT-PCR products were detected by using 
primer combination D1 & D2 and D3, & D4 (Figure 5.9.3, Figure 5.9.4). According 
to our results, both thrombospondin 1 and cytochrome b561 had a lower expression 
89 ., 
level in HSF (Figure 5.9.3, Figure 5.9.4). The difference in expression was more 
dramatic when using fewer cycles PCR (10 cycles). In this case, the reactions might 
remain in the exponential phase of the amplification process, and the amount of 
amplified products was proportional to the relative abundance of the starting mRNA 
(Chelly and Kahn, 1994). The expression of the housekeeping gene GAPDH, 
however, showed no significant difference in HSF and NF (Fig 5.9.5). These results 
showed that the expression of thrombospondin 1 and cytochrome b561 were down-
regulated in HSF. 
6.4 technical difficulties and limitations 
6.4.1 Sampling 
As there is still lack of animal model able to mimic the formation of 
hypertrophic scar in human, collection of the hypertrophic scar and the normal control 
skin can only rely on the surgical specimen. This is the most widely accepted 
approach (Ghahary et al. 1993, Messadi and Bertolami, 1993，Ghahary et al., 1995) 
but have the limitation to control the body location of the hypertrophic scar and the 
control normal skin. This sampling limitation may generate false positive result to the 
interpretation ofthe experiment result. Moreover, the supply of the clinical specimen 
is also very limited. During the period Sep 1996 to July 1998，there were about 20 
surgical cases of hypertrophic scar excision in the hand team of the department of 
Orthopedics and Traumatology in Prince of Wales hospital. However, less than half of 
these cases require grafting. Among these surgical cases, most of them were using 
partial thickness grafting which were not suitable to control the full thickness 
hypertrophic scar. Under these limitations, we could only collect three pairs of well 
control samples during the study period. 
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6.4.2 Primary tissue culture 
The major difficulty for handling the primary culture of human skin biopsies 
is micro-organism contamination. Although all surgical instruments and tissue 
surface, where the biopsy is taken, should have been sterilized before operation, they 
were still prone to be contaminated. In particular, the bacteria and the flingi in the hair 
follicles of the skin are extremely difficult to be removed or killed by the routine 
sterilization procedure. Antibiotics and fungizone additive may sometimes help but 
still are,incapable of preventing all contamination. 
\ 
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Part II Significance of the Findings and Future 
Studies 
6.5 Down-regulation of thrombospondin 1 (TSP 1) in the 
hypertrophic scar fibroblasts 
According to the findings presented in previous section, we concluded that the 
expression ofthrombospondin 1 (TSP 1) was down-regulated in the hypertrophic scar 
fibroblasts. The down-regulation of TSP 1 may mediate the hypertrophic scar ^ 
I 
formation in many aspects. To postulate the role of TSP 1 in hypertrophic scar 
formation, we have to understand the biochemical, biological and cellular functions of 
TSP 1 and its receptors relating to the cutaneous wound healing. 
6.6 Biochemical and biological functions of TSP 1 
TSP 1 is a trimeric 450 kDa, multifunction, and extracellular matrix 
glycoprotein. The schematic structure of TSP 1 is shown in Figure 6.1. This 
glycoprotein protein is released when platelets are activated, being the most abundant 
protein of platelet a-granules. On the other hand, it can be produced by a variety of 
different cell types, including keratinocytes (Hiscott et al., 1996), endothelial cells 
(Ramsby and Kreulzer, 1993), macrophages (DiPietro et al., 1996), mesangial cells 
(Hugo et aL, 1995), smooth muscle cells, neutrophil, monocyte (Salnikow et al., 
1997) as well as fibroblasts (Raugi et al, 1982). 
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Figure 6.1 Schematic models of the overall morphology and internal structure 
of thrombospondin. The top diagram shows the general shape of the glycoprotein 
thrombospondin-1, which is a trimer of identical subunits bonded together by 
disulfide bonds located near the smaller globular domain. The diagram at the bottom 
shows the structure of one subunit of thrombospondin-1. Globular domains are 
attached to ends of a rodlike segment consisting of three types of repeating unit 
termed type I, type II, and type III. There are at least four cell-binding sites in 
thrombospondin: the first two are in type I repeats and contain the Val-Thr-Cys-Gly 
sequence; they may bind to CD36 or platelet gpIV. The third cell-binding site is in a 
C-terminal type III repeating unit and contains the sequence Arg-Gly-Asp-. The 
fourth is in the carboxyl-terminal domain. In addition，the heparin-binding domain is 
reported to be a strong adhesion site in certain cells. Other binding sites include a 
procollagen-like domain thought to bind collagen and a calcium-binding domain, 
(modified from Yamada and Clark, 1996) 
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6.6.1 The biochemical functions of TSP 1 
In view of its multi-binding sites, it can modulate a wide variety of 
biochemical functions. It binds and activates the latent TGF-P (Murphy-Ullrich et al, 
1992). It also plays an important role in plasminogen activation in several manners: 
f 
(1) it is a slow, tight-binding inhibitor of plasmin; (2) it inhibits the activity of serine 
proteinase urokinase plasminogen activator (uPA), (3) but it stimulates the activity of 
another serine proteinase tissue plasminogen activator (tPA) (Hogg et al., 1992). It is 
also a tight-binding competitive inhibitor of neutrophil elastase (Hogg et al., 1993). 
TSP 1 can bind to a variety of extracellular matrix including proteoglycan, fibronectin 
\ 
and collagen (for an excellent review, see Yamada & Clark，1996). The summary of 
the biological functions ofTSPl is listed in Table 6.1 
Table 6.1 The biochemical functions of TSP 1 
Protein Effect References 
Latent TGf>P Activation Murphy-Ullrich et al., 1992 
Plasmin Inhibition Hogg et al, 1992 
uPA Inhibition Hogg et aL, 1992 
tPA Stimulation Hogg et al., 1992 
Neutrophil elastase Inhibition Hogg et aL, 1993 
Extracellular matrix protein - Binding For a review, Yamada and 




6.6.2 The biological functions of TSP 1 
TSP 1 can bind to cell surface receptors, mediate and modulate cell adhesion. 
It can promote or suppress the cell growth, and regulate the gene expression of the 
cell. The effects of TSP 1 to various cell types are different. It promotes attachment 
and spreading of keratinocytes O^^ickoloff et al., 1988)，but has an opposite effect on 
endothelial cells (Lahav, 1988). In addition, it inhibits the growth of megakaryocytic 
progenitor cells (Chen et al., 1996), and induces apoptosis of endothelial cells (Guo et 
al., 1997). It can up-regulate the expression of matrix metalloproteinase-9 (MMP 9) 
expression in endothelial cells (Qian et al., 1997) The summary of the cellular 
t 
interaction ofTSP 1 is shown in Table 6.2. 
Table 6.2 The biological functions of TSP 1 
Target cell Effects Reference 
Keratinocyte Promotes attachment Nickoloff et al., 1988 
Megakaryocytic progenitor Inhibits growth Chen et al., 1996 
cells 
Endothelial cell Induce apoptosis Guo et aL, 1997 
Inhibit proliferation Panetti et aL, 1997 
Up-regulate expression of Qian etaL, 1997 
MMP9 
Phagocytes Serve as an Intracellular- Savill et aL, 1992 
bridging molecule between 
the phagocyte and the 
apoptotic cell. Induce 
phagocytosis 
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The biological effect of TSP 1 to the endothelial cell and phagocytes will be 
further discussed in the following sections: The role of TSP 1 in the pathogenesis of 
hypertrophic scar. 
r 
6.7 The possible role of TSP 1 in the pathogenesis of 
hypertrophic scar 
As mentioned before, TSP 1 is a multi-flmctional protein and it is capable of 
mediating various cellular functions. Some of these cellular functions are closely 
related to wound healing. Hence, down-regulation of the expression of TSP 1 may 
relate to the pathogenesis of the formation ofhypertrophic scar. 
6.7.1 Down-regulation of TSP 1 may be responsible for the excessive 
microvessels in hypertrophic scar 
Numerous studies have accepted that TSP 1 is an inhibitor of angiogenesis 
(Lahav, 1988，Rastinejad et al., 1989, Panetti et aL, 1997, for an excellent review, see 
Iruela-Arispe and Dvorak, 1997). In spite of the various evidences of TSP 1 as 
inhibitor of angiogenesis, the mechanism ofhow TSP 1 mediates the inhibitory effect 
of angiogenesis is not clearly defined. However, several biochemical and biological 
functions were suspected responsible for its angiogenic inhibition effect and the 
model are shown in Figure 6.2. 
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Figure 6.2 Possible mechanisms by which TSP 1 inhibits angiogenesis. 
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One possible explanation is the reduction of survival-promoting signals of 
endothelial cells. Growth and survival of non-transformed endothelial cells depends 
on the adhesion of appropriate extracellular matrix. Fibronectin is one of the matrix 
proteins that provides these survival signals (Meredith et al., 1993). TSP 1 inhibits 
theadhesion ofendothelial cells to substrates coated with serum or fibronectin (Lahav 
et al., 1988)，probably be reducing the survival signals of endothelial cells. Recent 
study has also showed that TSP 1 can induce apoptosis of endothelial cells and this 
induction is closely related to fibronectin adhesion (Guo et aL, 1997). 
The other possible role of the angiogenesis inhibition effect of TSP 1 is the 
inhibition of urokinase plasminogen activator (uPA) activity (Hogg et al, 1992). 
Angiogenic factor such as bFGF has been shown to stimulate migration of large-
vessel and microvascular endothelial cells, and has been associated with the induction 
o f u P A (Pepper and Montesano, 1990). In contrast, anti-angiogenic factor such as 
angiotensin 2，which inhibits endothelial uPA and increase its inhibitor plasminogen 
activator inhibitor 1 (PAI-1), has been shown to inhibit endothelial cells migration 
(Bell and Madri, 1990). 
In view of the inhibitory effect of TSP 1 on angiogenesis being consistently 
observed, therefore, down-regulation of TSP 1 has been suggested to be associated 
with angiogenesis. In hyperplastic thyroid, angiogenesis is accompanied by an 
increase in FGF-2, and a decrease in TSP 1 (Patel et al., 1996). The induction ofthe 
angiogenic phenotype of the ornithine decarboxylase-overproducing NIH3T3 
transformed cells is likely due to decrease production and release of TSP 1 (Auvinen 
et aL, 1997). Loss ofthe wide-type allele of the p53 tumor leads to a reduction ofTSP 
1 expression, and switches the fibroblasts to an angiogenic phenotype (Castle et al, 
1997). Angiogenesis inhibitor SR 25989, however, up-regulates TSP 1 expression in 
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human vascular endothelial cells and fibroblasts (Klein-Soyer et al., 1997), and results 
in a concomitant increase in p53 protein level/expression. These findings suggested 
that the down-regulation of p53 suppresses TSP 1 expression and this suppression 
triggers the cell to differentiate into angiogenic phenotype. Hence, the down-
•f 
regulation ofTSP 1 in the hypertrophic scar fibroblasts can/may be responsible for the 
increase in the overall amount of microvessels in hypertrophic scar. 
6.7.2 Down-regulation of TSP 1 may be responsible for the failure of the 
apoptosis of the fibroblasts in the hypertrophic scar « 
The membrane glycoprotein CD36 is a major cell surface receptor for 
thrombospondin, although some cells appear to use the integrin avp3 (Savill et al, 
1992). These two receptors have been indicated to affect phagocyte recognition of the 
apoptotic cells (Savill et al, 1992, Ren et al, 1995, Rubartelli et al, 1997). 
One of the major cell types expressing these thrombospondin receptors is 
cytocidal macrophage (Savill et al, 1992, Savill et al, 1993). Both thrombospondin 
receptors CD36 and integrin avp3 on the macrophage surface are thought to mediate 
the recognition of the apoptotic cell by macrophage, and TSP 1 itself serves as an 
intracellular-bridging molecule between the macrophage and the apoptotic cell 
surface. The interaction of the surface receptors and TSP1 on the macrophage surface, 
and other factors involved in the clearance of granulocytes are shown in Figure 6.3. 
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Figure 6.3 The interaction between the phagocyte and the apoptotic cell. TSP 
1 receptors CD36 and avp3 play a crucial role for the phagocyte recognition of cells 
undergoes apoptosis. (modified from Savill et al, 1993) 
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As TSP 1 is suggested to be the bridge between the phagocyte and apoptotic 
cells, the down-regulation of the expression of TSP 1 in hypertrophic scar fibroblasts 
probably reduces the chance to be recognized by macrophages. This may be one of 
the mechanisms to protect the fibroblasts as well as myofibroblasts from undergoing 
apoptosis. 
The lack of apoptosis of the fibroblasts as well as myofibroblasts may play a 
very important role in the formation of hypertrophic scar and excessive scar 
contraction. 
V 
6.8 Expression of TSP 1 during Phase I and II of wound 
healing 
In view that TSP 1 has numerous biological functions, and it can be expressed 
by various cell types in the skin tissue, the relationship between cutaneous wound 
healing and the expression of TSP 1 has been appreciated recently. In linear excision 
model, TSP 1 appears extracellularly at the wound edge within 12 hr, and reaches in 
one to two days. However, its expression declines after day 3 (Reed MJ et al., 1993). 
In punch wound model, the expression of TSP 1 reaches maximal on day 2 in the 
macrophage-like cells and then slowly decreases (DiPieto et al., 1996). Recent study 
of adult bum wounds has shown that the expression of TSP 1 is primarily in the 
dermis, the microvessel-associated extracellular matrix, and basement membrane 
(Roth et aL, 1998). The expression level is maximal on day 2 followed by a steep 
decline，and returns as the normal skin day 9 post-bum. According to these findings, 
the expression level ofTSP 1 during wound healing can be presented as Figure 6.4. It 
is stressed that the expression level in the figure represents the summation of different 
cell types in the wound site. 
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Figure 6.4 The expression level of TSP 1 in wound healing during the early 
and the late phrase of inflammation. The phases of wound healing has arbitrarily 
divided as described by Clark (1996). The expression level of TSP 1 is plotted along 
the abscissa as a logarithm of time. 
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At the beginning of wound healing and early phrase of inflammation, the 
expression of TSP 1 increased dramatically. Platelet and macrophage should be 
responsible for the expression of TSP 1 in this healing phrase. The increase amount of 
TSP 1 in the wound site can facilitate the migration of keratinocyte (Nickoloff et al., 
/ 
1988). The expression level of TSP 1 drops rapidly during the late phrase of 
inflammation and the beginning of tissue formation, and returns to the level as the 
normal skin (Roth et aL, 1998). In this period, the TSP 1 producing cell type is still 
macrophage. Keratinocyte and fibroblast may also produce of TSP 1 but their 
contributions are much lower than that of macrophage. The decline of TSP 1 in the ^ 
wound site may reflect the decrease in the number of macrophage during resolution of 
the inflammation. This decline may also give a stop signal to keratinocyte migration 
after re-epithelialization. 
6.9 The Hypothetical Expression of TSP 1 during the whole 
process of wound healing 
However, the TSP 1 expression level after re-epithelialization and during 
tissue remodeling is still unknown. After re-epithelialization, the major cellular event 
in the wound site should be angiogenesis. In other hyperplastic studies (Patel et aL, 
1996), angiogenesis is associated with the down-regulation of TSP 1. By induction, 
we hypothesized that the expression level of TSP 1 in a normal wound site in the 
active angiogenesis phase should be down regulated too. In the phase III of wound 
healing (tissue remodeling), the excessive microvessels are regressed through 
apoptosis and the expression level of TSP 1 should go back to the normal skin level to 
achieve homeostasis. The hypothetical of TPS 1 expression level during the normal 
wound healing is shown in figure 6.5. 
103 
Tissue Tissue 
Inflammation formation remodeling Complete 
: Early Late 
phase phase 
Expression ！ ！ ！ 丨 ！ 
Level ofTSP1 I I I i I 
_ 
In Normal / ！ ! \ | | 
Skin i T ]y U^^^^^^^^^^3^-^ , . . 丨 
I I | v . ^ I 
1 — ‘ — I ~ ~ ‘ — I H H I i 
0.1 0.3 1 3 10 30 100 
Time (days) 
Figure 6.5 The hypothetical expression level of TSP 1 during the whole 
wound healing process. During re-epithelialization, the expression level of TSP 1 
should continuously decline to promote angiogenesis. During tissue remodeling, the 
expression level of TSP 1 should retain to the normal skin level to maintain 
homeostasis. The phases of wound healing has arbitrarily divided as described by 
Clark (1996). The expression level of TSP 1 is plotted along the abscissa as a 
logarithm of time. 
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During the phase II of wound healing (tissue formation), the major cells type 
responsible for TSP 1 expression should be endothelial cell and fibroblasts as most of 
macrophage has left the wound site. During the phase III of wound healing (tissue 
remodeling), the major cells types responsible for TSP 1 expression should be 
fibroblasts as the amount of endothelial cells is greatly reduced. 
6.10 The Hypothetical Expression of TSP 1 in hypertrophic 
scarring 
On the other hand, we found TSP 1 was down-regulated in the hypertrophic 
bum scar. In compound with the previous data about the bum wound, the hypothetical 
model of the expression level of TSP 1 in hypertrophic scarring as shown in Figure 
6.6. The fibroblasts in the hypertrophic scar may be arrested on the angiogenic 
phenotype. Moreover, the down-regulation of TSP 1 in the hypertrophic scar 
fibroblast also helps fibroblast protect from ingestion by the phagocyte. 
It is stressed that all these hypothetical models are only based on induction 
from the present available knowledge about TSP 1. Up to date，there is still lack of 
finding about the expression pattem of TSP 1 in the latter ^)hase II and phase III) 
healing phases as well as in the hypertrophic scar. 
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Figure 6.6 The hypothetical expression level of TSP 1 in hypertrophic 
scarring. After re-epithelialization, the expression level of TSP 1 in the hypertrophic 
scar is down-regulated and unable to retain to the normal skin level. This down-
regulation of TSP 1 may prolong angiogenesis, and causes the excessive microvessels 
formation in the hypertrophic scar. The phases of wound healing has arbitrarily 
divided as described by Clark (1996). The expression level of TSP 1 is plotted along 
the abscissa along the abscissa as a logarithm oftime. 
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6.11 Cytochrome b561 and its biological function 
Cytochrome b561 is an integral membrane protein and was first discovered in 
catecholamine storage granules (Srivastava et al., 1993). This 30 kDa protein 
comprises 15% of the granule membrane protein and appear to act as a 
V 
transmembrane electron shuttle between the cytoplasm and granule matrix. Recent 
study has proposed that the gene product is likely to be distributed within the 
membrane with five transmembrane helices (Srivastava, 1995). 
.Cytochrome b561 is found in many neuroendocrine tissues (Fleming & Kent， 
1991). It is present in splenic nerve terminals and posterior and anterior hypophysis; � 
in most areas ofthe brain; in blood vessels, retina, gut, endocrine cells, and heart; in 
thyroid parafollicular cells; in sympathetic nerve terminals of the vas deferens, the 
islets ofLangerhans ofthe angler fish, and platelet serotinin granules. It is also found 
to be highly expressed in colon cancer cells lines, T cell lymphomas, and K-562 cell 
lines. However, the expression of cytochrome b561 in fibroblasts has never been 
reported. Present study is the first report to demonstrate the expression of cytochrome 
b561 in human dermal fibroblasts. 
The function of cytochrome b561 is suggested to transfer reducing equivalents 
from cytoplasmic ascorbate to the intravesicular monooxygenase dopamine b-
hydroxylase in catecholamine storage granules and peptidyl glycine a-amidating 
monooxygenase in neurosecretory peptide storage vesicles (Srivastava et al., 1996). 
Howver, none of data about the function of cytochrome b561 in fibroblasts is 
available up to date. 
One possible role for cytochrome b561 in fibroblasts is the modulation ofthe 
intracellular ascorbate QSljus et aL, 1991). Ascorbate is able to induce the production 
of collagen I and III and prohibit the production of elastin in fibroblasts at 
107 
transcription level (Davidson et al., 1996). Therefore, we suspect that the down-
regulation of cytochrome b561 in the hypertrophic scar fibroblasts may induce its 
collagen I and III production through regulate the intracellular ascorbate level. The 
precise functions of cytochrome b561 expression in fibroblasts should be ftoher 
f 
studied. 
6.12 Future studies 
6.12.1The expression of TSP 1 in hypertrophic scarring and normal 
wound healing ^ 
i 
Recent studies have showed that the expression ofTSP 1 in different cell types 
is regulated in the cutaneous wound healing. However, its expression is only studied 
in the early phase of wound healing. The expression of TSP 1 during the phase II or 
phase III of wound healing and hypertrophic scarring is still undefined. We have 
hypothesized the pattem of expression of TSP 1 in hypertrophic scarring as well as 
normal wound healing, and these hypothetical models were listed in the sections 6.8 
and 6.9. Further research to test these hypotheses is needed. Comparing the profile of 
the expression ofTSP 1 between the normal wound healing and hypertrophic scarring 
process should provide the better understanding of the role of TSP 1 in the 
pathogenesis of hypertrophic scar. Furthermore, it could allow the new therapeutic 
strategies for the treatment ofhypertrophic scar. 
Besides studying the regulation of TSP 1 in the cultured fibroblasts, 
localization the expression ofTSPl in vivo can provide a more thorough idea ofthe 
spatial variation of the TSP 1 expression. In this aspect, in situ hybridization is a 
direct approach to study the mRNA expression whereas immuno-histochemical 
staining is a direct approach to localize the protein distribution. 
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Anti-sense approach can be used to block the expression of TSP 1 in cultured 
fibroblasts. By comparing the other known differentially expressed genes in 
hypertrophic scar fibroblasts and the anti-sense treated normal skin fibroblasts, the 
regulation effects ofTSP 1 to these altered genes can be identified. 
6.12.2The expression of cytochrome b561 in dermal fibroblast 
This is the first report about the expression of cytochrome b561 in dermal 
fibroblasts. No information about the role of cytochrome b561 in fibroblasts is 
available to date. Anti-sense approach and over-expression approach can promisingly » 
provide insight for understanding the biological role of cytochrome b561 in dermal 
fibroblasts. 
In addition, localization of the expression of cytochrome b561 in vivo in 
wound healing and hypertrophic scarring is also important to provide insight to 
understand its biological role in the pathogenesis ofhypertrophic scar. 
6.12.3Aful[ scale study of differential display RT-PCR 
Only 4 anchored down primers and 12 arbitrary upstream primers were 
applied in the present study. By increasing the combination of the primers, we can 
expect to identify more differentially expressed genes. 
In order to get rid of the problem of undetectable, overlapping or unresolved 
cDNA fragments from the differentially expressed band, single strand conformation 
polymorphism (SSCP) should be performed after the first reamplification as this 
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Appendix 丨 
The complete mRNA sequence of thrombospondin 1 precursor 
1 gccgccctcg ccaccgctcc cggccgccgc gctccggtac acacaggatc cctgctgggc 
61 accaacagct ccaccatggg gctggcctgg ggactaggcg tcctgttcct gatgcatgtg 
121 tgtggcacca accgcattcc agagtctggc ggagacaaca gcgtgtttga catctttgaa 
181 ctcaccgggg ccgcccgcaa ggggtctggg cgccgactgg tgaagggccc cgacccttcc 
241 agcccagctt tccgcatcga g§atgccaac ctgatccccc ctgtgcctga tgacaagttc 
301 caagacctgg tggatgctgt gcggacagaa aagggtttcc tccttctggc atccctgagg 
361 cagatgaaga agacccgggg cacgctgctg gccctggagc ggaaagacca ctctggccag 
421 gtcttcagcg tggtgtccaa tggcaaggcg ggcaccctgg acctcagcct gaccgtccaa 
481 ggaaagcagc acgtggtgtc tgtggaagaa gctctcctgg caaccggcca gtggaagagc 
54i atcaccctgt ttgtgcagga agacagggcc cagctgtaca tcgactgtga aaagatggag 
601 aatgctgagt tggacgtccc catccaaagc gtcttcacca gagacctggc cagcatcgcc 
661 agactccgca tcgcaaaggg gggcgtcaat gacaatttcc agggggtgct gcagaatgtg 
721: aggtttgtct ttggaaccac accagaagac atcctcagga acaaaggctg ctccagctct 
781 accagtgtcc tcctcaccct tgacaacaac gtggtgaatg gttccagccc tgccatccgc 
841 actaactaca ttggccacaa gacaaaggac ttgcaagcca tctgcggcat ctcctgtgat 
901 gagctgtcca gcatggtcct ggaactcagg ggcctgcgca ccattgtgac cacgctgcag 
961 gacagcatcc gcaaagtgac tgaagagaac aaagagttgg ccaatgagct gaggcggcct 
1021 cccctatgct atcacaacgg agttcagtac agaaataacg aggaatggac tgttgatagc 
1081 tgcactgagt gtcactgtca gaactcagtt accatctgca aaaaggtgtc ctgccccatc 
1141 atgccctgct ccaatgccac agttcctgat ggagaatgct gtcctcgctg ttggcccagc 
1201 gactctgcgg acgatggctg gtctccatgg tccgagtgga cctcctgttc tacgagctgt 
1261 ggcaatggaa ttcagcagcg cggccgctcc tgcgatagcc tcaacaaccg atgtgagggc 
1321 tcctcggtcc agacacggac ctgccacatt caggagtgtg acaagagatt taaacaggat 
1381 ggtggctgga gccactggtc cccgtggtca tcttgttctg tgacatgtgg tgatggtgtg 
1441 atcacaagga tccggctctg caactctccc agcccccaga tgaacgggaa accctgtgaa 
1501 ggcgaagcgc gggagaccaa agcctgcaag aaagacgcct gccccatcaa tggaggctgg 
1561 ggtccttggt caccatggga catctgttct gtcacctgtg gaggaggggt acagaaacgt 
1621 agtcgtctct gcaacaaccc cacaccccag tttggaggca aggactgcgt tggtgatgta 
1681 acagaaaacc agatctgcaa caagcaggac tgtccaattg atggatgcct gtccaatccc 
1741 tgctttgccg gcgtgaagtg tactagctac cctgatggca gctggaaatg tggtgcttgt 
1801 ccccctggtt acagtggaaa tggcatccag tgcacagatg ttgatgagtg caaagaagtg 
1861 cctgatgcct gcttcaacca caatggagag caccggtgtg agaacacgga ccccggctac 
1921 aactgcctgc cctgcccccc acgcttcacc ggctcacagc ccttcggcca gggtgtcgaa 
1981 catgccacgg ccaacaaaca ggtgtgcaag ccccgtaacc cctgcacgga tgggacccac 
2041 gactgcaaca agaacgccaa gtgcaactac ctgggccact atagcgaccc catgtaccgc 
2101 tgcgagtgca agcctggcta cgctggcaat ggcatcatct gcggggagga cacagacctg 
2161 gatggctggc ccaatgagaa cctggtgtgc gtggccaatg cgacttacca ctgcaaaaag 
2221 gataattgcc ccaaccttcc caactcaggg caggaagact atgacaagga tggaattggt 
2281 gatgcctgtg atgatgacga tgacaatgat aaaattccag atgacaggga caactgtcca 
2341 ttccattaca acccagctca gtatgactat gacagagatg atgtgggaga ccgctgtgac 
2401 aactgtccct acaaccacaa cccagatcag gcagacacag acaacaatgg ggaaggagac 
2461 gcctgtgctg cagacattga tggagacggt atcctcaatg aacgggacaa ctgccagtac 
2521 gtctacaatg tggaccagag agacactgat atggatgggg ttggagatca gtgtgacaat 
2581 tgccccttgg aacacaatcc ggatcagctg gactctgact cagaccgcat tggagatacc 
2641 tgtgacaaca atcaggatat tgatgaagat ggccaccaga acaatctgga caactgtccc 
2701 tatgtgccca atgccaacca ggctgaccat gacaaagatg gcaagggaga tgcctgtgac 
2761 cacgatgatg acaacgatgg cattcctgat gacaaggaca actgcagact cgtgcccaat 
2821 cccgaccaga aggactctga cggcgatggt cgaggtgatg cctgcaaaga tgattttgac 
2881 catgacagtg tgccagacat cgatgacatc tgtcctgaga atgttgacat cagtgagacc 
2941 gatttccgcc gattccagat gattcctctg gaccccaaag ggacatccca aaatgaccct 
3001 aactgggttg tacgccatca gggtaaagaa ctcgtccaga ctgtcaactg tgatcctgga 
3C61 ctcgctgtag gttatgatga gtttaatgct gtggacttca gtggcacctt cttcatcaac 
121 
3121 accgaaaggg acgatgacta tgctggattt gtctttggct accagtccag cagccgcttt 
3181 tatgttgtga tgtggaagca agtcacccag tcctactggg acaccaaccc cacgagggct 
3 241 cagggatact cgggcctttc tgtgaaagtt gtaaactcca ccacagggcc tggcgagcac 
3301 ctgcggaacg ccctgtggca cacaggaaac acccctggcc aggtgcgcac cctgtggcat 
3361 gaccctcgtc acataggctg gaaagatttc accgcctaca gatggcgtct cagccacagg 
3421 ccaaagacgg gtttcattag agtggtgatg tatgaaggga agaaaatcat ggctgactca 
.3481 ggacccatct atgataaaac ctatgctggt ggtagactag ggttgtttgt cttctctcaa 
‘3541 gaaatggtgt tcttctctga cctgaaatac gaatgtagag atccctaatc atcaaattgt 
3601 tgattgaaag actgatcata aaccaatgct ggtattgcac cttctggaac tatgggcttg 
3661 agaaaacccc caggatcact tctccttggc ttccttcttt tctgtgcttg catcagtgtg 
3721 gactcctaga acgtgcgacc tgcctcaaga aaatgcagtt ttcaaaaaca gactcagcat 
3781 tcagcctcca atgaataaga catcttccaa gcatataaac aattgctttg gtttcctttt 
3841 gaaaaagcat ctacttgctt cagttgggaa ggtgcccatt ccactctgcc tttgtcacag 
3901 agcagggtgc tattgtgagg ccatctctga gcagtggact caaaagcatt ttcaggcatg 
3961 tcagagaagg gaggactcac tagaattagc aaacaaaacc accctgacat cctccttcag 
4021 gaacacgggg agcagaggcc aaagcactaa ggggagggcg catacccgag acgattgtat 
4081 gaagaaaata tggaggaact gttacatgtt cggtactaag tcattttcag gggattgaaa 
4141 gactattgct ggatttcatg atgctgactg gcgttagctg attaacccat gtaaataggc 
4201 acttaaatag aagcaggaaa gggagacaaa gactggcttc tggacttcct ccctgatccc 
4261 cacccttact catcacctgc agtggccaga attagggaat cagaatcgaa accagtgtaa 
4321 ggcagtgctg gctgccattg cctggtcaca ttgaaattgg tggcttcatt ctagatgtag 




The mRNA sequence of cytochrome b561 
f 
1 cgcatctcag gcgcagtctc taggggctgt gcgcatccta gggggggaca tgtgcatctc 
61 aggggggctg ctcgcatctg gggggtgctg tgtgcatctc gggggggctg tgcatctagc 
121 ggggtggctg tgtccgcatc tggagggggc tgtgcgcaac ccgggggggg tgttgcgcgc 
181 atctagcagg ggcggctgtg cgcatttcgg gggggggctg tgcatatctg gggggaccgt 
241 gcttatctct gggggcggct gtgcgcatct tgaggggtgt gtacatctcg gggggcctgt 
301 gcgcatcttg gggggctgtg tgcatccgcg ggggctgtgc gcatctcggg tgctgtgcgc 
361 tgctcctctg agctctgctc tttcttgcag cgtttgcctc agccatggag ggcggggccg 
421 cggcagccac ccccacagca ctgccttact acgtggcctt ctcccagctg ctgggcctga 
481 ccttggtggc catgaccggc gcgtggctcg ggctgtaccg aggcggcatt gcctgggaga 
541 gcgacctgca gttcaacgcg caccccctct gcatggtcat aggcctgatc ttcctgcagg 
601 gaaatgccct gctggtttac cgtgtcttca ggaacgaagc taaacgcacc accaaggtcc 
661 tgcacgggct gctgcacatc tttgcgctcg tcatcgccct ggttggcttg gtggcggtgt 
721 tcgactacca caggaagaag ggctacgctg acctgtacag cctacacagc tggtgcggga 
781 tccttgtctt tgtcctgtac tttgtgcagt ggctggtggg cttcagcttc ttcctgttcc 
841 ccggagcttc attctccctg cggagccgct accgcccaca gcacatcttc tttggtgcta 
901 ccatcttcct ccttcccgtg ggcaccgccc tgctgggcct gaaggaggca ctgctgttca 
961 acctcggggg caagtatagc gcatttgagc ccgagggtgt cctggccaac gtgctgggcc 
1021 tgctgctggc ctgcttcggt ggggcggtgc tctacatctt gacccgggcc gactggaagc 
1081 ggccttccca ggcggaagag caggccctct ccatggactt caagacgctg aggcagggag 
1141 atagccccgg ctcccagtga tgcgcccggc cggccctggg ggttcgcggg gtgtcttctt 
1201 gcctgcccct gctgaggcgt cttcaggact gcaggctccg gagagtggct ctggcagcag 
1261 gcgggcgggt gggtgcaggg ggatccgttt gatgcgtcgt ttctggggca ggtctccgcc 
1321 tcctctgctt ctcgtttctc cgctgctata gaccagttca ttgtgtgtgg ctcccgtgtc 
1381 tctgttgccc ccttcagtgc agaaggcttt gggtagactt cgggtgttcg gtcctggtcg 
1441 cagagcacag atctttaaag aagcgttaga gaggtaggtt ctaccctctt ggtagtagat 
1501 gcctggggca aggcccaggg gaaactgggg gggcctcagg gacaggcctg gaaaggccac 
1561 gatggcctgc tgaattcaaa caaggagtcc ctccagcctg aataacacgt ggcacaaatg 
1621 ggcccggcct ttggcagagg agcaagtgat atgatgtgta aagtatgttg gtggtgaaag 
1681 caaggttccc caggagaggg gagggactgg cccctgggaa gctctgagat gaggctgtgg 
1741 cccagctgta gtcctgacct tactcttctt taaaaccctt tagccctagg atggctttgg 
1801 tgggagaggg gatagaagcc catgacttca gacagacttt ctcttggcag atgcaggcag 
1861 gcctcctccc aggctgctcc agacatgggg gttggggatg gggggtacct tgcagcccct 
1921 tcctgctggg gctccctcct tgtagcaccc ccttgcggct cagctctggt ttcctctccc 
1981 aggctcaccc aggctctgct caggctggga ggcagagggc acaaacctta taatttttta 
2041 aatgaaaaac cgctgctgct ggctgtggct agagccccct ggggctgctg gagctgctgc 
2101 ctctgttctg gaggacgagc cttctcctta tctgctgccc atctttccag gaagtcagga 
2161 tggagtcaga caactaacga tcatcccccg tggtgtctgc acatcactcc agccccataa 
2221 agagtgtcat gttagctgag tcaccatttg gcttcggcct ggaaatagtg tgttagaaca 
2281 ctgatcgtgt gcgaggccag gagatcaaga ccatcctgac taacaaacac agtgaaaccc 
2341 cgtctctacg gaattccctg tattagtcta tatggttctc caagaaactg aatgaatcca 
2401 ttggagaagc ggtggataac tagccagaca aaatttgaga atacataaac aacgcattcc 
2461 gcaggaaaca tacagaggat gccttttctg tgattgggtg ggattttttc cctttttatg 
2521 tggatatagt agttacttgt gacaagaata attttggaat aatttctatt aatatcaact 
2581 ctgaagctaa ttgtacataa tctcgagatt gtgtttgttc ataataaaag tgaagtgaat 
2641 ctg 
123 
ll 1 ^ i ^ ^ J l i J ^ ^ l J ^ , i j ^ l l ^
 






- . 「 
t 
, <
 , ' w ^ . . ^ ^ ^ h . p . ^ ^




• 養 。 〜
 
• ， . ：
. .
. 善 _ 













, : i ; 






























 : ( ) - , - . " . - - .
 心








_ _ l i 
• 0 3 7 0 5 1 0 7 
